US20070281371A1 - Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles - Google Patents
Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles Download PDFInfo
- Publication number
- US20070281371A1 US20070281371A1 US11/709,068 US70906807A US2007281371A1 US 20070281371 A1 US20070281371 A1 US 20070281371A1 US 70906807 A US70906807 A US 70906807A US 2007281371 A1 US2007281371 A1 US 2007281371A1
- Authority
- US
- United States
- Prior art keywords
- fluid
- analyte
- wave device
- fluid chamber
- plate wave
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N29/00—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object
- G01N29/02—Analysing fluids
- G01N29/022—Fluid sensors based on microsensors, e.g. quartz crystal-microbalance [QCM], surface acoustic wave [SAW] devices, tuning forks, cantilevers, flexural plate wave [FPW] devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N29/00—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object
- G01N29/02—Analysing fluids
- G01N29/036—Analysing fluids by measuring frequency or resonance of acoustic waves
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N29/00—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object
- G01N29/44—Processing the detected response signal, e.g. electronic circuits specially adapted therefor
- G01N29/4409—Processing the detected response signal, e.g. electronic circuits specially adapted therefor by comparison
- G01N29/4418—Processing the detected response signal, e.g. electronic circuits specially adapted therefor by comparison with a model, e.g. best-fit, regression analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0681—Filter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
- B01L2300/1805—Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks
- B01L2300/1822—Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks using Peltier elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/043—Moving fluids with specific forces or mechanical means specific forces magnetic forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2291/00—Indexing codes associated with group G01N29/00
- G01N2291/02—Indexing codes associated with the analysed material
- G01N2291/025—Change of phase or condition
- G01N2291/0256—Adsorption, desorption, surface mass change, e.g. on biosensors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2291/00—Indexing codes associated with group G01N29/00
- G01N2291/02—Indexing codes associated with the analysed material
- G01N2291/028—Material parameters
- G01N2291/02836—Flow rate, liquid level
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2291/00—Indexing codes associated with group G01N29/00
- G01N2291/04—Wave modes and trajectories
- G01N2291/042—Wave modes
- G01N2291/0422—Shear waves, transverse waves, horizontally polarised waves
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2291/00—Indexing codes associated with group G01N29/00
- G01N2291/04—Wave modes and trajectories
- G01N2291/042—Wave modes
- G01N2291/0423—Surface waves, e.g. Rayleigh waves, Love waves
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2291/00—Indexing codes associated with group G01N29/00
- G01N2291/04—Wave modes and trajectories
- G01N2291/042—Wave modes
- G01N2291/0426—Bulk waves, e.g. quartz crystal microbalance, torsional waves
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2291/00—Indexing codes associated with group G01N29/00
- G01N2291/04—Wave modes and trajectories
- G01N2291/042—Wave modes
- G01N2291/0427—Flexural waves, plate waves, e.g. Lamb waves, tuning fork, cantilever
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the present invention relates to sensors for detecting analyte in liquid samples.
- analytes e.g., biological agents
- concentration issues generally arise since the concentrations of such analytes tend to be low.
- biological analytes e.g., cells, cell fragments and macromolecules such as proteins and nucleic acids
- transport issues arise because these larger analytes diffuse in fluid solution very slowly.
- a key metric for competitive detection is the amount of analyte accumulated on a sensor per unit time. For good performance, the rate of accumulation (and the resulting signal transient) needs to be fast relative to the sensor drift rate.
- Another key performance metric for an analyte detection system is the degree to which the system can preferentially collect the analyte of interest on the sensor surface. Since many biological samples contain extraneous background components (e.g., other proteins, cells, nucleic acids, dirt), it is necessary to prevent these background components from interfering with the desired measurement. So, a transport method that selectively draws the analyte to the sensor and allows interfering background components to pass by has definite advantages. Such a method used in concert with selective binding of the analyte (e.g., antibody, complimentary DNA strands, etc.) to the sensor surface can deliver high sensitivity measurements for samples with large amounts of extraneous background components relative to the amount of analyte.
- the analyte e.g., antibody, complimentary DNA strands, etc.
- Electrodesis and dielectrophoresis have been used to enchance transport but are not universally applicable to all analytes and sample types. They are generally more effective for larger analytes (e.g., cells). Furthermore, the electrical properties of microbes can vary within a given species and strain, making it hard to predict system performance under all intended operating conditions. Sometimes it is necessary to tailor the ionic strength of the sample to improve the performance of the transport. This requirement can conflict with the optimum binding or wash conditions in an assay. Also, electrical fields can dissipate energy and heat conductive fluids (e.g, 0.1 M phosphate buffer solution), which is undesirable since heating can damage the biological analytes.
- energy and heat conductive fluids e.g, 0.1 M phosphate buffer solution
- Immunomagnetic separation (IMS) methods are known in the art for isolating analyte from a sample.
- an analyte binds to a magnetic particle (e.g., a magnetic bead) to form an analyte-particle complex.
- the analyte-particle complex is transported and localized onto the surface of a sensing device by applying a gradient magnetic field.
- the magnetic field induces a polarization in the magnetic material of the particle that is aligned with the local magnetic field lines.
- the particle experiences a net force in the direction of the gradient, causing the particle to migrate toward regions of higher field strength.
- the magnetic field distribution is tailored to draw analyte-particle complexes from a sample flow and distribute them across the surface of the sensing device.
- the extraneous, background components of the sample e.g., cells, proteins
- the extraneous, background components of the sample generally have a much lower magnetic susceptibility as compared to the magnetic particles, and so the magnetic field does not significantly influence them.
- the magnetic field does not significantly influence them.
- only a very small fraction of this background material interacts with the sensor surface.
- the sensing device in the described embodiment is a flexural plate wave (FPW) device, which functions particularly well with the magnetic particles for two reasons.
- FPW flexural plate wave
- the presence of the magnetic particles on the surface of the sensing device results in an amplified FPW signal response.
- the larger combined size and density of the analyte-particle complex yields a larger FPW signal response than the analyte alone.
- the surface of the sensor in the FPW device consists of a thin membrane that is typically only a few micrometers thick, which allows larger magnetic fields and field gradients to be created at the sensor surface because the field source can be positioned closer to the sample flow. This results in higher fractional capture of the analyte from the sample. With this higher capture rate and efficiency, it is possible to process larger sample volumes in shorter times than would be otherwise possible.
- an apparatus for detection of an analyte includes a fluid chamber having at least one opening for fluid to enter, and a flexural plate wave device defining at least a portion of at least one interior surface of the fluid chamber.
- the apparatus further includes a monitoring device to monitor at least one signal output by the flexural plate wave device, a plurality of magnetic particles coated with a capture agent having an affinity for the analyte, and a first source of magnetic flux to selectively attract magnetic particles to the at least one interior surface of the fluid chamber.
- a cartridge for a resonant device system in another aspect, includes a first fluid chamber having at least one opening for fluid to enter, and a flexural plate wave device defining at least one interior surface of the fluid chamber.
- the apparatus further includes a first source of magnetic flux to selectively attract magnetic particles to the at least one interior surface of the first fluid chamber.
- a method for detection of an analyte includes combining a fluid containing an analyte with a plurality of magnetic particles that comprise a capture agent having an affinity for the analyte to produce at least some magnetic particles bound to at least some analyte.
- the method further includes directing the combined fluid into a first fluid chamber, wherein at least one surface of a flexural plate wave device is in fluid communication with the fluid in the first fluid chamber.
- the method also includes creating a first magnetic flux in proximity to the flexural plate wave device to magnetically attract at least some of the bound magnetic particles to the at least one surface of the flexural plate wave device.
- a method for detection of an analyte includes coating at least a portion of a surface of a flexural plate wave device located in a fluid chamber with a first capture agent, and directing a fluid containing an analyte into the fluid chamber to bind some of the analyte to the capture agent located on the flexural plate wave device.
- the method further includes directing a fluid containing a plurality of magnetic particles that comprise a second capture agent into the fluid chamber, and creating a magnetic flux in proximity to the flexural plate wave device to attract at least some of the magnetic particles towards the surface of the flexural plate wave device.
- FIG. 1A shows one embodiment of an analyte detection system, constructed according to the invention.
- FIG. 1B shows another embodiment of a portion of the analyte detection system shown in FIG. 1A .
- FIG. 2 shows a more detailed view of the FPW sensor shown in FIG. 1A .
- FIG. 3 shows a general detection protocol for using an FPW sensor in combination with analyte-particle complexes for detection of biological analytes.
- FIG. 4 shows the change in the signal from multiple FPW sensors as a function of time for an exemplary detection protocol.
- FIG. 5 is a summary plot showing the final signal change detected as a function of original analyte concentration.
- FIG. 6 shows a time evolution plot for a detection protocol, similar to the plot shown in FIG. 4 , but rather for a PSA analyte.
- FIG. 1A One embodiment of an analyte detection system 100 , constructed according to the invention, is shown in FIG. 1A .
- the system 100 includes a network of channels 102 for transporting various test solutions (also referred to herein as “test fluids” or “fluids”) through an FPW device 104 .
- test fluids also referred to herein as “test fluids” or “fluids”.
- FPW device 104 includes a network of channels 102 for transporting various test solutions (also referred to herein as “test fluids” or “fluids”) through an FPW device 104 .
- test fluids also referred to herein as “test fluids” or “fluids”
- FPW device 104 The following U.S. Patents and Patent Applications, all of which are hereby incorporated by reference, describe examples of the various types of FPW devices suitable for use in the present invention: U.S. Pat. Nos. 5,129,262, 5,189,914, 6,688,
- U.S. Pat. No. 5,129,262 describes an ultrasonic sensor that has a thin planar sheet of material forming a Lamb wave propagation medium.
- Lamb waves also known as plate-mode waves, can propagate only through a material of finite thickness.
- SAWs surface acoustic waves
- Lamb waves require a propagation medium having a thickness on the order of hundreds of times the wavelength of the propagating SAW, Lamb waves require a propagation medium which is at most only several wavelengths thick, and typically only a fraction of the wavelength of the propagating Lamb wave.
- the thickness of the sheet is no greater than about twenty microns.
- a Lamb wave generator generates Lamb waves in the planar sheet, and an output device produces an electrical signal that represents the propagation characteristics of the Lamb waves propagating along the sheet.
- a measuring device measures selected characteristics of the output electrical signal.
- the planar sheet has some physical characteristics that depend upon the value of a measurand acting on the sheet, and those physical characteristics consequently determine the propagation characteristics of the Lamb waves that propagate along the sheet. Since the electrical signal from the output device represents the propagation characteristics, the electrical signal also represents the value of the measurand acting on the sheet.
- the Lamb wave device described in U.S. Pat. No. 5,129,262 can be employed, for example, in biological sensing.
- the planar sheet described above can be pre-coated with antibody molecules, so that the frequency of the device changes upon immersion in or contact with a liquid that contains the corresponding antigen.
- Antigen-antibody attachment at the surface of the propagation medium acts to alter the wave velocity of the Lamb waves in the sheet.
- the change in wave velocity causes the oscillation frequency to change in a delay line oscillator form of the device.
- the sheet may be made of a porous and permeable material, allowing the coating of antibody molecules over a greater surface area of the sheet and also allowing the antigen-containing liquid to be flowed through the membrane, in order to speed up the antigen-antibody attachment.
- Other biological interactions may also be sensed, and additional applications include immunoassay, clinical laboratory testing, in vivo biomedical monitoring, and biomedical research.
- test solutions used in the described embodiment are sourced from reservoir containers 112 .
- the channel path from each of the reservoirs 112 is gated with a valve 114 to control the flow of a particular test solution to a combination point 116 leading to an entry port 118 of the FPW device 104 .
- the test solution flows through the FPW device 104 and exits via an exit port 120 , which leads to a pump 122 .
- the pump 122 draws the test solution through the network of channels 102 and through the FPW device 104 , and directs the test solution to a waste receptacle 124 .
- FIG. 1B shows another embodiment of the analyte detection system 100 .
- This embodiment packages the FPW device 104 and its associated fluid chamber 160 as a cartridge 103 , i.e., a consumable component that can be removed and replaced.
- Some embodiments may include a fluid control device 101 such as a plug, obstruction or baffle that alters the flow through the device 104 .
- the fluid control device 101 operates to cause the fluid flow through the device 104 to pass closer to the sensor surface 143 than if the fluid control device 101 was not present.
- the source of input test solutions is shown as an input fluid chamber 105 that has an outlet 107 for directing the test solutions into the inlet 109 of the cartridge 103 .
- the magnetic particles are initially located in the input fluid chamber 105 and the fluid containing analyte is mixed with the magnetic particles in the input fluid chamber 105 and then directed into the cartridge 103 in which the FPW device 104 is located.
- the magnetic particles may be combined within the input fluid chamber 105 with the fluid containing analyte by a device (e.g., by the action of a pump or a magnetic agitator).
- FIG. 1B further shows an output fluid chamber 111 with an inlet 113 that receives fluid from the outlet 115 of the cartridge 103 .
- This output fluid chamber 111 may include one or more of the fluid control devices described herein, and it may include one or more mechanisms for storing and/or treating waste fluid.
- the junction where the outlet 107 of the input fluid chamber 105 meets the inlet 109 of the cartridge 103 is constructed and arranged to allow repeatable connection and disconnection.
- the junction where the outlet 115 of the cartridge 103 meets the inlet 113 of the output fluid chamber 111 is constructed and arranged to allow repeatable connection and disconnection.
- these junctions are constructed and arranged to require tools for connection and disconnection, such as threaded couplings that require a wrench or other such tool to affect the coupling and decoupling.
- these junctions are constructed and arranged to allow quick and easy manual connection and disconnection, without any extra tools or accessories. Such couplings, both requiring and not requiring tools, are known in the art.
- one or more input and/or output fluid chambers are part of the cartridge 103 .
- one or more sources of magnetic flux are part of the cartridge.
- the FPW device 104 is shown in more detail in FIG. 2 and FIG. 2A .
- strain energy is carried in bending and tension in the device.
- the wavelength “ ⁇ ” of the FPW device 104 is approximately equal to the pitch of the interdigitated electrodes as described herein.
- the thickness-to-wavelength ratio of the FPW device 104 is 2 ⁇ m/38 ⁇ m.
- the FPW device 104 is designed to isolate a particular mode (e.g., any mode from the zero th order mode to higher order modes) or bandwidth of modes associated with the device.
- a particular mode e.g., any mode from the zero th order mode to higher order modes
- bandwidth of modes associated with the device For example, an FPW device 104 having a thickness/wavelength of 2 ⁇ m/38 ⁇ m as described above would isolate the 80 th mode of the FPW device 104 .
- the FPW device 104 can be designed to achieve this effect by selecting a particular pattern for the interdigitated electrodes deposited on the device.
- the FPW device 104 is rectangular in shape.
- the FPW device 104 can, alternatively, be circular or elliptical, or some other planar shape.
- the FPW device 104 is constructed from a silicon wafer 130 , using micro-fabrication techniques known in the art.
- a cavity 132 is etched into the wafer 130 to produce a thin, suspended membrane 134 that is approximately 1.6 mm long, 0.3 mm wide and 2 ⁇ m thick.
- the overall wafer 130 thickness is approximately 500 ⁇ m, so the depth of the cavity 132 is just slightly less than the wafer 130 thickness.
- a 0.5 ⁇ m layer 136 of aluminum nitride (AlN) is deposited on the outer surface (i.e., the surface opposite the cavity 132 ) of the membrane 134 , as shown in the expanded view insert of FIG. 2A .
- Two sets of inter-digitated metal electrodes 138 are deposited upon the AlN layer.
- a thin layer 140 of gold (approximately 500 angstroms) is deposited on the inner surface (i.e., the surface facing the cavity 132 ) of the membrane 134 to facilitate immobilization of capture agents (described in more detail below).
- instrument/control electronics 126 apply a time-varying electrical signal to at least one set of electrodes 138 to generate vibrations in the suspended membrane 134 .
- the instrument/control electronics 126 also monitor the vibrational characteristics of the membrane 134 by receiving a sensor signal from at least a second set of electrodes 138 .
- the maximal response of the plate structure is around 15-25 MHz.
- the instrument/control electronics 126 compare a reference signal to the sensor signal from the second set of electrodes to determine the changes in the relative magnitude and phase angle of the sensor signal as a function of frequency.
- the instrument/control electronics 126 interpret these changes to detect the presence of the targeted analyte.
- the instrument/control electronics also determines, for example, the concentration of the targeted analyte on the inner surface of the membrane 134 .
- Capture agents targeting the analyte of interest are immobilized on the thin layer of gold 140 covering the inner surface of the membrane 134 , as described above.
- Thiol-terminated alkyl chains are linked to the gold surface forming a self-assembled monolayer (SAM).
- a fraction of the SAM chains are terminated with reactive groups (e.g, carboxyl) to allow covalent linking of capture agents to the SAM chains using biochemical process steps known in the art.
- the remainder of the SAM chains are terminated with non-reactive groups, preferably ones that have a hydrophilic character to resist nonspecific binding (e.g., oligomers of ethylene glycol).
- Other surface chemistries are described in the literature and can be used to produce a capture surface.
- the FPW device 104 is packaged to allow electrical connections to the electrodes 138 on the outer surface of the membrane 134 . Additionally, the FPW device 104 is mechanically supported by a channel block 142 , to allow for the inner surface of the membrane 134 to contact the test solutions and an interface is provided for contacting the sensor surface 143 with the liquid sample.
- the channel block 142 creates a path (fluid chamber 160 ) for the test solutions to flow from an input port 118 , past the inner surface of the membrane 134 and then out of an exit port 120 .
- a seal 144 is formed between the FPW device 104 and the channel block 142 to prevent test solutions from escaping from the channels 102 formed within the combination of the FPW device 104 and the channel block 142 .
- the channel block 142 thus forms a fluid chamber, of which the FPW device 104 comprises one of the interior walls.
- the channels 102 through the combination of the FPW device 104 and the channel block 142 are approximately 0.5 mm in diameter.
- the channel block 142 can be formed from a variety of materials, including plastic, metal or ceramic, among other materials.
- the system 100 includes one or more fluid control devices for changing at least one fluid property, such as flow, pressure, or trajectory to name a few, within the system 100 .
- the pump 122 and valves 114 shown in FIG. 1A that direct and control the flows of various test solutions through the device and over the sensor surface 143 (as required to execute a test protocol) are all examples of fluid control devices.
- a fluid control device changes the at least one fluid property in the vicinity of at least one surface within the fluid chamber 160 of the device 104 . Generally, this is done to distribute the magnetic particles along at least a portion of the sensor surface 143 .
- the fluid control device is a pump (e.g., a peristaltic pump, centrifugal pump, rotary pump, electro-osmotic pump).
- the pump is located on the entrance side of the fluid chamber, and in other embodiments the pump is located on the exit side of the fluid chamber.
- the device is a flow diverter (e.g., a plug, obstruction wall or baffle) that is disposed relative to the fluid chamber to alter the fluid flow in the vicinity of the at least one interior surface of the fluid chamber.
- a single pump 122 is positioned on the waste side of the FPW device 104 . Suction that the pump 122 generates draws buffer 110 or analyte in the sample 108 from their respective reservoir containers 112 on the supply side of the FPW device 104 . Valves 114 are positioned on the supply side of the device 104 to control which test solution is directed over the sensor surface 143 at any time during the test protocol. The pump 122 controls the flow rate of the test.
- a device for regulating temperature may be associated with the FPW device 104 and channel block 142 . This reduces the impact of variable environmental conditions on the FPW device 104 output by maintaining the device 104 at a relatively constant, known temperature.
- a temperature sensor is included within the system 100 , for example as part of the FPW device 104 .
- the sensor signal from the FPW device 104 is scaled, at a specific instant in time (or during a period of time), based on the output of the temperature sensor, in order to produce a signal that is independent of the effects of temperature variations. This scaling could be done based on a mathematical model, or an analytical model, or some hybrid combination of a mathematical and analytical model.
- a filter is included in the path of the test solution to selectively filter particles (e.g., magnetic particles and biological materials) of a particular size to prevent them from entering the fluid chamber.
- a particular testing protocol may include steps for changing the filter during the test. This would allow different types (i.e., sizes) of analytes and magnetic particles to be directed into the fluid chamber, and thereby tested by the system 100 , during different portions of the test.
- Magnetic particles e.g., paramagnetic or super-paramagnetic beads or microspheres
- a capture agent e.g., a capture agent
- analyte-particle complexes 146 result as do particles 147 that have bound nonspecific materials and particles 148 that have bound nothing.
- the particles 146 , 147 and 148 are located in the sample reservoir 112 .
- the system 100 further includes a magnetic field inducing structure 150 for producing magnetic flux in the vicinity of the membrane 134 .
- the source of magnetic flux is a retractable magnet 150 arranged to normally be in close proximity to the membrane 134 of the FPW device 104 .
- the magnet 150 produces a significant gradient magnetic field in the vicinity of the membrane 134 .
- the retractable magnet 150 can be retracted away from the membrane 134 by a distance sufficient to substantially reduce magnetic fields in the vicinity of the membrane 134 .
- the magnet 150 when in close proximity to the membrane 134 , the magnet 150 is situated approximately 200 ⁇ m from the sensor surface 143 of the membrane 134 .
- the magnet 150 is situated between about 50 ⁇ m to about 100 ⁇ m from the sensor surface 143 of the membrane 134 .
- the magnet 150 When the magnet 150 is in close proximity to the membrane 134 , the magnet 150 provides a source of magnetic flux to draw the magnetic particles from the sample to the sensor surface 143 .
- the analyte-particle complexes 146 migrate from the liquid sample until they encounter the sensor surface 143 .
- the analyte binds with the capture agent on the sensor surface 143 .
- the analyte forms a link between the magnetic particle and sensor surface.
- the particles 147 with non-specially bound material and particles 148 with nothing bound are held at the sensor surface 143 by the magnetic field.
- weak binding forces can act between the particles 146 , 147 , and 148 and the sensor surface 143 .
- the magnet 150 is retracted to reduce the magnetic force experienced by the particles that have accumulated at the sensor surface 143 .
- the wash flow rate is increased to remove particles 147 and 148 that are not bound to the surface by analyte. Since the particles 147 with nonspecifically bound material as well as particles 148 with nothing bound are more weakly linked to the sensor surface 143 than the analyte-particle complexes 146 , they release from the sensor surface 143 at a lower wash flowrate (and corresponding hydrodynamic force).
- removing the magnet 150 i.e., substantially reducing the magnetic force experienced by the particles 146 , 147 , and 148 at the sensor surface 143 ) is used to distinguish between particles with analyte 146 from those without (particles 147 and 148 ).
- One technique for engaging and retracting the magnet 150 is to mount it on a carriage (not shown) that is actuated by a cam system (not shown).
- the magnet 150 material, geometry and distance from the sensor surface 143 determine the field shape and field gradient, and therefore, the force that the analyte-particle complexes 146 experience.
- High strength permanent magnets for use as the retractable magnet 150 are available commercially.
- 1 mm diameter cylindrical NdFeB magnets can be purchased from several vendors (e.g., Dexter Magnetic Technologies).
- a 1 mm diameter and 5 mm long NdFeB magnet 150 is positioned within 0.1 mm of the sensor surface 143 when engaged. When retracted the magnet 150 is at least 0.5 mm from the sensor surface 143 .
- the membrane 134 of the FPW device 104 is very thin (2 ⁇ m) and made of nonmagnetic materials (e.g., silicon, aluminum nitride or gold), the membrane 134 does not significantly perturb the magnetic field on the sensor surface 143 side of the device 104 . As a result, very high magnitude magnetic fields and large field gradients can be achieved, as is necessary for high collection efficiencies.
- the sample flow rate through the channels 102 is determined (e.g., specified by an operator) by the residence time necessary for good collection efficiency.
- the sample flow rate is adjusted so that the average velocity over the sensor surface 143 is between about 1 and about 5 mm/s. With an iron oxide paramagnetic particle with a diameter of approximately 3 ⁇ m, collection efficiencies approaching 50% can be achieved.
- the source 150 of magnetic flux i.e., the magnet
- an electromagnet can be used instead of a permanent magnet.
- the electromagnet includes pole pieces that extend to focus the field flux near the sensor surface 143 of the device 104 .
- a magnetizable material can be fashioned and positioned adjacent to the sensor surface 143 (within 0.1 mm), and a separate magnet combined with an open face of the magnetizable material to induce a magnetic field in the magnetizable material.
- the magnetic field induced in the material serves to locate desirable field gradients near the sensor surfaces 143 .
- useful materials for this purpose are pure iron, high mu metals such as alloy 49 (high nickel content iron), sna silicon steels (1-2% silicon typical).
- a low precision actuator can be used for engaging and retracting the magnet since the magnet need only contact the ferromagnetic core or be fully withdrawn.
- the magnet 150 is positioned in close proximity to the sensor surface 143 , a higher level of precision is required to achieve good assay repeatability. Although there is some loss of field strength with this approach, it is still possible to design the overall system to achieve good capture efficiencies (e.g., >10%).
- the shape of the tip of the field inducing structure may be tailored to enhance and/or concentrate the field gradient at the surface. Since the size of the FPW device 104 (e.g., 0.3 mm ⁇ 1.6 mm) is typically smaller than conventionally formed magnets or machined inductors, the portion of the field inducing structure adjacent to the membrane 134 can be tapered to concentrate the magnetic field in one or more locations on the sensor surface 143 . Tapering the tip acts to increase both the local field magnitude and the local field gradients. For example, a wedge-shaped tip is well suited to the current FPW device geometry.
- One embodiment of the system 100 includes an optional second source 150 a of magnetic flux that opposes or partially opposes the first source 150 of magnetic flux.
- This second source 150 a of magnetic flux can be used to dislodge some of the magnetic particles that have adhered to the sensor surface 143 . It may, for example, dislodge magnetic particles 148 that do not have any bound analyte; they would not be as strongly attached to the sensor surface 143 as the particles 146 that do have bound analyte.
- the first source 150 of magnetic flux is turned off or moved away from the sensor surface 143 and then, the second source 150 a of magnetic flux is positioned relative to the at least one surface of the fluid chamber to selectively remove magnetic particles.
- This may be done, for example, to remove magnetic particles 148 that do not have any bound analyte and therefore they are not as strongly bound to the sensor surface 143 . This would achieve a similar effect as increasing the flow of fluid to remove magnetic particles 148 that do not have any bound analyte.
- Controlling the distribution of the analyte-particle complexes 146 on the surface 143 of the device 104 can improve the device performance, since the device 104 has a suspended membrane 134 and not all parts of the membrane 134 contribute equally to the moving mass of the detectable resonance.
- the system 100 can be constructed and arranged to distribute the analyte-particle complexes 146 within one third of the FPW device 104 width along the middle two-thirds of the centerline of the long axis of the membrane 134 .
- the shape of the tip of the field-inducing structure e.g., magnet 150
- the shape of the tip of the field-inducing structure can be such that the field magnitude and field gradient increase in the direction of the flow over the sensor membrane 134 .
- analyte-particle complexes 146 in the downstream regions, where the boundary layer is partially depleted of analyte experience a higher field and field gradient than do analyte-particle complexes 146 in the upstream regions.
- the system 100 can be constructed and arranged to concentrate magnetic particles in one or more particular regions of the sensor surface 143 .
- the response of the device 104 may not be uniform over the sensor surface 143 due to characteristics of the fabrication materials or the specifics of the sensor design.
- high sensitivity regions of the device 104 may be non-uniform and asymmetrical with respect to the long and short axis centerlines of the device 104 .
- the tip of the field inducing structure may be shaped to concentrate magnetic particles in the region or regions of highest sensitivity.
- Varying the flow rate through the device 104 can also be used to achieve a more uniform coverage of analyte-particle complexes 146 for a given magnetic field distribution.
- magnetic particles interact with the sensor surface 143 as determined by the bulk fluid flow rate, much like a ballistic object might fall in the presence of the gravity body force. In this case, however, the magnetic induced force dominates.
- the analyte-particle complexes 146 can be caused to interact with the sensor surface 143 at substantially different locations along the stream-wise flow direction.
- the flow can be reversed and subsequently pulsed forward in order to pull the pile over and thus communicate more particles with the sensor surface 143 .
- selective location of the magnetic particles along the sensor surface 143 is achieved by selectively altering, over the course of the detection protocol, either one or both of the magnetic flux source and the property or properties of the fluid flow along the sensor surface 143 .
- One embodiment of the system 100 includes a device (e.g., optical, magnetic) for characterizing at least one property of the magnetic particles that are attached or attracted to the sensor surface 143 .
- This device could be an integral part of the FPW device 104 , or it could be a part of the magnet 150 , or it could be a discrete component apart from other components of the system 100 .
- Such a device may be used to detect the presence of the particles, and also to determine parameters related to the particle, for example, the size, quantity, concentration, or density of the particles that are attracted to the sensor surface 143 .
- One embodiment of the system 100 includes an identification device for allowing an operator or computer to identify the system 100 or a particular component of the system for tracking usage of the system or component.
- the identification device may include a symbol or image such as a bar code, an identification number, or other identifying mark.
- the identification device may include an actual component, passive or active, such as an RFID tag, an integrated circuit or other such component known in the art for providing identifying information. Many such devices are known in the art, although any contemplated identification device may be used.
- a general detection protocol 200 for using an FPW device 104 in combination with analyte-particle complexes 146 for detection of biological analytes is shown in FIG. 3 .
- the first step 202 of the detection protocol 200 is acquiring and preparing 202 the analyte sample.
- Various preparation processes may need to be performed prior to testing, depending upon the particular type of analyte being tested. For example, to detect microbes in food (e.g., E. coli in ground beef), a sample would be first mixed with enrichment broth, stomached, incubated and filtered. For detecting proteins in blood, the sample would first be filtered or centrifuged and the serum separated. Specific examples of test protocols that include sample preparation steps are described herein.
- the next step 204 of the detection process is mixing affinity-coated paramagnetic particles (i.e., beads) with the prepared analyte sample.
- Paramagnetic or super-paramagnetic particles are available commercially from a number of vendors (e.g., Dynal Biotech, Oslo, Norway). Typical diameters range from 50 nm to 10 ⁇ m, and such particles can be procured already coated with affinity agents (e.g., antibodies, proteins, and nucleic acid probes) targeting a variety of analytes (e.g., cells, proteins and nucleic acids).
- affinity agents e.g., antibodies, proteins, and nucleic acid probes
- analytes e.g., cells, proteins and nucleic acids
- the particles can be purchased with various reactive chemical groups (e.g., epoxy, carboxyl, and amine) in order to attach a capture agent of choice. Standard biochemical protocols are available for this purpose.
- the sample with paramagnetic particles added is agitated 206 for an amount of time determined by the particular analyte and capture agent. During this process, the particles bind with analyte so that the analyte is captured on the particles. In some cases, the sample can be tested directly at this point. But, in other cases it is advantageous to perform separation steps 208 to isolate the analyte bound to the particles from the rest of the original sample. These separation steps 208 reduce interference from other biological material in the assay. Manual or automated equipment for performing such separation steps is available commercially (e.g., Dexter Magnetic Technologies, Dynal Biotech). The basic process uses a magnet to localize the paramagnetic particles on a surface so that the majority of the sample liquid can be aspirated. The magnet (e.g., magnet 150 of FIG. 1A ) is then removed, and clean buffer solution is added to re-suspend the particles.
- the basic process uses a magnet to localize the paramagnetic particles on a surface so that the majority of
- a baseline step 210 is executed prior to testing the processed analyte sample with the FPW device 104 .
- a reference solution 106 is flowed through the system to rinse/block the sensor 104 , and the instrument/control electronics 126 excite the device 104 and records the resulting initial baseline signal from the device 104 .
- a sample transport step 212 follows the baseline step 210 .
- the sample 108 containing the analyte-particle complexes 146 is flowed over the sensor surface 143 with the magnet 150 engaged.
- Analyte-particle complexes 146 are collected on the sensor surface 143 .
- the magnet 150 is retracted to release the particles 147 and 148 from the sensor surface 143 that do not have bound analyte, and the flow is switched to a wash solution (e.g., buffer solution 110 ).
- the flow rate of the wash solution is increased to help remove loosely bound particles 147 and 148 , as well as other material in the sample that may have bound to the sensor surface 143
- An acquisition step 214 follows the sample transport step 212 .
- Reference solution 106 is again run through the device 104 , and the instrument/control electronics 126 excite the device 104 to acquire and record a final baseline signal from the device 104 .
- the system 100 determines the amount of analyte accumulated on the sensor surface 143 during the transport step 212 by comparing 216 the initial baseline signal and the final baseline signal, which correspond to the vibrational characteristics of the FPW device 104 in the reference solution before and after, respectively, the acquisition step 214 .
- Analyte-particle complexes 146 bound to the sensor surface 143 change the vibrational characteristics of the FPW device 104 , and the amount of change to the vibrational characteristics correspond to the amount of anaylyte-particle complexes bound to the sensor surface 143 .
- FIG. 4 shows the change in the signal from multiple FPW devices 104 as a function of time for an exemplary detection protocol.
- the square symbols correspond to a device 104 exposed to an analyte; the triangles and stars correspond to negative controls (in which there is no analyte on the beads).
- the data shown in FIG. 4 (and FIG. 5 as described below) represent an exemplary detection protocol for which the analyte is E. coli bacteria, or generally a cellular analyte.
- FIG. 4 shows that the resonant frequency of the FPW device 104 decreases as the magnetic particles 146 , 147 and 148 accumulate on the surface. Once the magnet 150 is removed and some of the magnetic particles are washed away, the frequency of the device 104 increases. Eventually, the system establishes a final baseline that can be compared to the initial baseline taken at the start of the test, or to that of a control.
- FIG. 5 is a summary plot showing the final signal change detected as a function of original analyte concentration.
- FIG. 6 shows a time evolution plot for a detection protocol, similar to the one shown in FIG. 4 .
- FIG. 6 depicts a detection protocol for a PSA assay, which demonstrates the capability of the system 100 for detecting proteins.
- the flow direction can be reversed during the protocol. For example, reversing the flow direction may be useful for washing nonspecifically bound material from the device, or for making more efficient use of the available sample.
- Another variation in the detection protocol includes alternating between wash steps and binding steps. This can allow better use of the dynamic range of the device. In come cases, a large fraction of the particles do not have bound analyte, especially at low analyte concentrations. By repeatedly binding and washing away particles, it is possible to accumulate more analyte-particle complexes 146 and, hence, improve the sensitivity of the measurement.
- Changing or manipulating the magnetic field distribution at the sensor surface 143 during the transport step 212 can enhance the probability that the analyte attached to a particular particle encounters the sensor surface 143 .
- the spatial distribution of the field is alternated during binding, it is possible to cause the paramagnetic particles at the sensor surface 143 to roll.
- an operator or the instrument/control electronics 126 can be used to control the rolling of the paramagnetic particles along the sensor surface 143 .
- introducing a second magnetic field (i.e., a second source of magnetic flux) in the system 100 can improve the control of the assay conditions and enhance the specificity of the assay.
- a secondary magnetic field i.e., a second source of magnetic flux
- applying a secondary magnetic field to the sensor surface 143 can act to pull off weakly bound magnetic particles.
- the strength of the secondary field can be tailored to generate a force on the analyte-particle complexes 146 at the sensor surface 143 that is below the binding force of the specifically bound analyte but above the typical binding force for nonspecifically bound material. This sequence of steps can be repeated multiple times during the assay to further increase the specificity of the test.
- the relative binding strength of the various analyte-particle complexes 146 on the sensor surface 143 can be determined by increasing (continuously or discretely) this magnetic pull-off force during the wash step, while monitoring the response of the FPW device 104 . Information on the relative binding strength can be used to distinguish between different analytes in the sample 108 .
- the system 100 flows the sample through a channel to establish contact between the analyte-particle complexes 146 and the sensor surface 143 .
- the FPW device 104 is mounted on a probe and at least partially immersed into a test solution containing magnetic particles bound to an analyte.
- the immersion is sufficient to place the bound magnetic particles in proximity to the sensor surface 143 so that the particles are attracted toward the sensor surface 143 and subsequently detected, as described herein.
- the device 104 (or cartridge 103 ) is immersed in a reference test solution.
- a portion of the device 104 (e.g., the membrane 134 ) is mounted to a probe. Further, only part of the sensor surface 143 of the membrane 134 is placed in contact with the solution containing magnetic particles bound to an analyte. In these embodiments, immersion or controlled movement of the probe in the fluid is sufficient to place the bound magnetic particles in proximity to the sensor surface 143 so that the particles are attracted toward the sensor surface 143 and subsequently detected.
- Another alternative embodiment of the system 100 involves mounting the device 104 inside of a tube that can be partially immersed into a well holding the sample 108 , and then retracted.
- a pump applies suction to draw sample into the tube and over the sensor surface 143 (or cartridge 103 ) when the sample is immersed.
- the sample is then ejected back into the well by reversing the pump or simply by venting the tube. This cycle of drawing and releasing the sample can be repeated to improve the collection efficiency and, therefore, the performance of the assay.
- FIG. 5 Contains Data Representative of Various Concentrations of E. coli ).
- PSA Prostate Specific Antigen
Abstract
A system for detecting an analyte in a sample includes a resonant sensor that has a sensor surface coated with the capture agent. A plurality of magnetic particles, each of which is coated with a capture agent having an affinity for the analyte, is combined with the sample to form a plurality of analyte-particle complexes. The system also includes a transport arrangement for transporting the sample to the sensor surface, and a magnetic field inducing structure constructed and arranged to establish a magnetic field at and adjacent to the sensor surface. The resonant sensor produces a signal corresponding to an amount of analyte-particle complexes that are bound to the sensor surface.
Description
- This is a divisional of prior application Ser. No. 11/183,484, filed on Jul. 18, 2005, which claims priority of Application Ser. No. 60/690,592, filed Jun. 15, 2005 and Ser. No. 60/676,759, filed on May 2, 2005.
- The present invention relates to sensors for detecting analyte in liquid samples.
- Significant challenges for a system that detects analytes (e.g., biological agents) in liquid media include concentration of the analyte in the media, and transport of the analyte to a sensor surface. For biological applications, concentration issues generally arise since the concentrations of such analytes tend to be low. Additionally, biological analytes (e.g., cells, cell fragments and macromolecules such as proteins and nucleic acids) tend to be relatively large; hence, transport issues arise because these larger analytes diffuse in fluid solution very slowly. A key metric for competitive detection is the amount of analyte accumulated on a sensor per unit time. For good performance, the rate of accumulation (and the resulting signal transient) needs to be fast relative to the sensor drift rate.
- Another key performance metric for an analyte detection system is the degree to which the system can preferentially collect the analyte of interest on the sensor surface. Since many biological samples contain extraneous background components (e.g., other proteins, cells, nucleic acids, dirt), it is necessary to prevent these background components from interfering with the desired measurement. So, a transport method that selectively draws the analyte to the sensor and allows interfering background components to pass by has definite advantages. Such a method used in concert with selective binding of the analyte (e.g., antibody, complimentary DNA strands, etc.) to the sensor surface can deliver high sensitivity measurements for samples with large amounts of extraneous background components relative to the amount of analyte.
- Various methods for improving transport of analyte to a sensor surface have been proposed, including filtration, novel flow geometries, acoustic fields, electrical fields (time varying and static) and magnetic fields.
- Acoustic excitation has been used to draw cells to field nodes, but it is difficult to use this technique alone to transport material to a surface.
- Electrical fields (electrophoresis and dielectrophoresis) have been used to enchance transport but are not universally applicable to all analytes and sample types. They are generally more effective for larger analytes (e.g., cells). Furthermore, the electrical properties of microbes can vary within a given species and strain, making it hard to predict system performance under all intended operating conditions. Sometimes it is necessary to tailor the ionic strength of the sample to improve the performance of the transport. This requirement can conflict with the optimum binding or wash conditions in an assay. Also, electrical fields can dissipate energy and heat conductive fluids (e.g, 0.1 M phosphate buffer solution), which is undesirable since heating can damage the biological analytes.
- Immunomagnetic separation (IMS) methods are known in the art for isolating analyte from a sample.
- In the described embodiment of an analyte detection system, an analyte binds to a magnetic particle (e.g., a magnetic bead) to form an analyte-particle complex. The analyte-particle complex is transported and localized onto the surface of a sensing device by applying a gradient magnetic field. The magnetic field induces a polarization in the magnetic material of the particle that is aligned with the local magnetic field lines. The particle experiences a net force in the direction of the gradient, causing the particle to migrate toward regions of higher field strength. The magnetic field distribution is tailored to draw analyte-particle complexes from a sample flow and distribute them across the surface of the sensing device. The extraneous, background components of the sample (e.g., cells, proteins) generally have a much lower magnetic susceptibility as compared to the magnetic particles, and so the magnetic field does not significantly influence them. Hence, only a very small fraction of this background material interacts with the sensor surface.
- The sensing device in the described embodiment is a flexural plate wave (FPW) device, which functions particularly well with the magnetic particles for two reasons. First, the presence of the magnetic particles on the surface of the sensing device results in an amplified FPW signal response. The larger combined size and density of the analyte-particle complex yields a larger FPW signal response than the analyte alone. Second, the surface of the sensor in the FPW device consists of a thin membrane that is typically only a few micrometers thick, which allows larger magnetic fields and field gradients to be created at the sensor surface because the field source can be positioned closer to the sample flow. This results in higher fractional capture of the analyte from the sample. With this higher capture rate and efficiency, it is possible to process larger sample volumes in shorter times than would be otherwise possible.
- In one aspect, an apparatus for detection of an analyte includes a fluid chamber having at least one opening for fluid to enter, and a flexural plate wave device defining at least a portion of at least one interior surface of the fluid chamber. The apparatus further includes a monitoring device to monitor at least one signal output by the flexural plate wave device, a plurality of magnetic particles coated with a capture agent having an affinity for the analyte, and a first source of magnetic flux to selectively attract magnetic particles to the at least one interior surface of the fluid chamber.
- In another aspect, a cartridge for a resonant device system includes a first fluid chamber having at least one opening for fluid to enter, and a flexural plate wave device defining at least one interior surface of the fluid chamber. The apparatus further includes a first source of magnetic flux to selectively attract magnetic particles to the at least one interior surface of the first fluid chamber.
- In another aspect, a method for detection of an analyte includes combining a fluid containing an analyte with a plurality of magnetic particles that comprise a capture agent having an affinity for the analyte to produce at least some magnetic particles bound to at least some analyte. The method further includes directing the combined fluid into a first fluid chamber, wherein at least one surface of a flexural plate wave device is in fluid communication with the fluid in the first fluid chamber. The method also includes creating a first magnetic flux in proximity to the flexural plate wave device to magnetically attract at least some of the bound magnetic particles to the at least one surface of the flexural plate wave device.
- In another aspect, a method for detection of an analyte includes coating at least a portion of a surface of a flexural plate wave device located in a fluid chamber with a first capture agent, and directing a fluid containing an analyte into the fluid chamber to bind some of the analyte to the capture agent located on the flexural plate wave device. The method further includes directing a fluid containing a plurality of magnetic particles that comprise a second capture agent into the fluid chamber, and creating a magnetic flux in proximity to the flexural plate wave device to attract at least some of the magnetic particles towards the surface of the flexural plate wave device.
- The foregoing and other objects of this invention, the various features thereof, as well as the invention itself, may be more fully understood from the following description, when read together with the accompanying drawings in which:
-
FIG. 1A shows one embodiment of an analyte detection system, constructed according to the invention. -
FIG. 1B shows another embodiment of a portion of the analyte detection system shown inFIG. 1A . -
FIG. 2 shows a more detailed view of the FPW sensor shown inFIG. 1A . -
FIG. 3 shows a general detection protocol for using an FPW sensor in combination with analyte-particle complexes for detection of biological analytes. -
FIG. 4 shows the change in the signal from multiple FPW sensors as a function of time for an exemplary detection protocol. -
FIG. 5 is a summary plot showing the final signal change detected as a function of original analyte concentration. -
FIG. 6 shows a time evolution plot for a detection protocol, similar to the plot shown inFIG. 4 , but rather for a PSA analyte. - One embodiment of an
analyte detection system 100, constructed according to the invention, is shown inFIG. 1A . Thesystem 100 includes a network ofchannels 102 for transporting various test solutions (also referred to herein as “test fluids” or “fluids”) through anFPW device 104. The following U.S. Patents and Patent Applications, all of which are hereby incorporated by reference, describe examples of the various types of FPW devices suitable for use in the present invention: U.S. Pat. Nos. 5,129,262, 5,189,914, 6,688,158 B2, U.S. patent application Ser. No. 10/324,685, U.S. Pat. Nos. 5,668,303, 5,836,203, and U.S. patent application Ser. No. 20040038195. - For example, U.S. Pat. No. 5,129,262 describes an ultrasonic sensor that has a thin planar sheet of material forming a Lamb wave propagation medium. Lamb waves, also known as plate-mode waves, can propagate only through a material of finite thickness. In contrast to surface acoustic waves (SAWs), which require a propagation medium having a thickness on the order of hundreds of times the wavelength of the propagating SAW, Lamb waves require a propagation medium which is at most only several wavelengths thick, and typically only a fraction of the wavelength of the propagating Lamb wave. The thickness of the sheet is no greater than about twenty microns. A Lamb wave generator generates Lamb waves in the planar sheet, and an output device produces an electrical signal that represents the propagation characteristics of the Lamb waves propagating along the sheet. A measuring device measures selected characteristics of the output electrical signal. The planar sheet has some physical characteristics that depend upon the value of a measurand acting on the sheet, and those physical characteristics consequently determine the propagation characteristics of the Lamb waves that propagate along the sheet. Since the electrical signal from the output device represents the propagation characteristics, the electrical signal also represents the value of the measurand acting on the sheet.
- The Lamb wave device described in U.S. Pat. No. 5,129,262 can be employed, for example, in biological sensing. The planar sheet described above can be pre-coated with antibody molecules, so that the frequency of the device changes upon immersion in or contact with a liquid that contains the corresponding antigen. Antigen-antibody attachment at the surface of the propagation medium acts to alter the wave velocity of the Lamb waves in the sheet. The change in wave velocity causes the oscillation frequency to change in a delay line oscillator form of the device. Also, the sheet may be made of a porous and permeable material, allowing the coating of antibody molecules over a greater surface area of the sheet and also allowing the antigen-containing liquid to be flowed through the membrane, in order to speed up the antigen-antibody attachment. Other biological interactions may also be sensed, and additional applications include immunoassay, clinical laboratory testing, in vivo biomedical monitoring, and biomedical research.
- The test solutions used in the described embodiment, for example a
blocking solution 106, asample 108, and abuffer 110, are sourced fromreservoir containers 112. The channel path from each of thereservoirs 112 is gated with avalve 114 to control the flow of a particular test solution to acombination point 116 leading to anentry port 118 of theFPW device 104. The test solution flows through theFPW device 104 and exits via anexit port 120, which leads to apump 122. Thepump 122 draws the test solution through the network ofchannels 102 and through theFPW device 104, and directs the test solution to awaste receptacle 124. -
FIG. 1B shows another embodiment of theanalyte detection system 100. This embodiment packages theFPW device 104 and its associatedfluid chamber 160 as acartridge 103, i.e., a consumable component that can be removed and replaced. Some embodiments may include afluid control device 101 such as a plug, obstruction or baffle that alters the flow through thedevice 104. In one embodiment, thefluid control device 101 operates to cause the fluid flow through thedevice 104 to pass closer to thesensor surface 143 than if thefluid control device 101 was not present. Further, the source of input test solutions is shown as aninput fluid chamber 105 that has anoutlet 107 for directing the test solutions into theinlet 109 of thecartridge 103. In some embodiments, the magnetic particles are initially located in theinput fluid chamber 105 and the fluid containing analyte is mixed with the magnetic particles in theinput fluid chamber 105 and then directed into thecartridge 103 in which theFPW device 104 is located. The magnetic particles may be combined within theinput fluid chamber 105 with the fluid containing analyte by a device (e.g., by the action of a pump or a magnetic agitator).FIG. 1B further shows anoutput fluid chamber 111 with aninlet 113 that receives fluid from theoutlet 115 of thecartridge 103. Thisoutput fluid chamber 111 may include one or more of the fluid control devices described herein, and it may include one or more mechanisms for storing and/or treating waste fluid. - In at least one embodiment, the junction where the
outlet 107 of theinput fluid chamber 105 meets theinlet 109 of thecartridge 103 is constructed and arranged to allow repeatable connection and disconnection. Similarly, the junction where theoutlet 115 of thecartridge 103 meets theinlet 113 of theoutput fluid chamber 111 is constructed and arranged to allow repeatable connection and disconnection. In some embodiments, these junctions are constructed and arranged to require tools for connection and disconnection, such as threaded couplings that require a wrench or other such tool to affect the coupling and decoupling. In other embodiments, these junctions are constructed and arranged to allow quick and easy manual connection and disconnection, without any extra tools or accessories. Such couplings, both requiring and not requiring tools, are known in the art. In some embodiments, there are multiple input fluid chambers and output fluid chambers. In some embodiments, one or more input and/or output fluid chambers are part of thecartridge 103. Further, in some embodiments, one or more sources of magnetic flux are part of the cartridge. - The
FPW device 104 is shown in more detail inFIG. 2 andFIG. 2A . In anFPW device 104, strain energy is carried in bending and tension in the device. In some embodiments, it is desirable for the thickness-to-wavelength ratio of theFPW device 104 to be less than one, and in some cases much less than one. In general, the wavelength “λ” of theFPW device 104 is approximately equal to the pitch of the interdigitated electrodes as described herein. In one embodiment, the thickness-to-wavelength ratio of theFPW device 104 is 2 μm/38 μm. In other embodiments, theFPW device 104 is designed to isolate a particular mode (e.g., any mode from the zeroth order mode to higher order modes) or bandwidth of modes associated with the device. For example, anFPW device 104 having a thickness/wavelength of 2 μm/38 μm as described above would isolate the 80th mode of theFPW device 104. TheFPW device 104 can be designed to achieve this effect by selecting a particular pattern for the interdigitated electrodes deposited on the device. In one embodiment, theFPW device 104 is rectangular in shape. TheFPW device 104 can, alternatively, be circular or elliptical, or some other planar shape. - In general, the
FPW device 104 is constructed from asilicon wafer 130, using micro-fabrication techniques known in the art. In the described embodiment, acavity 132 is etched into thewafer 130 to produce a thin, suspendedmembrane 134 that is approximately 1.6 mm long, 0.3 mm wide and 2 μm thick. Theoverall wafer 130 thickness is approximately 500 μm, so the depth of thecavity 132 is just slightly less than thewafer 130 thickness. A 0.5μm layer 136 of aluminum nitride (AlN) is deposited on the outer surface (i.e., the surface opposite the cavity 132) of themembrane 134, as shown in the expanded view insert ofFIG. 2A . Two sets ofinter-digitated metal electrodes 138 are deposited upon the AlN layer. Athin layer 140 of gold (approximately 500 angstroms) is deposited on the inner surface (i.e., the surface facing the cavity 132) of themembrane 134 to facilitate immobilization of capture agents (described in more detail below). - In operation, instrument/control electronics 126 (referring to
FIG. 1A ) apply a time-varying electrical signal to at least one set ofelectrodes 138 to generate vibrations in the suspendedmembrane 134. The instrument/control electronics 126 also monitor the vibrational characteristics of themembrane 134 by receiving a sensor signal from at least a second set ofelectrodes 138. When liquid is in contact with thecavity side 132 of themembrane 134, the maximal response of the plate structure is around 15-25 MHz. The instrument/control electronics 126 compare a reference signal to the sensor signal from the second set of electrodes to determine the changes in the relative magnitude and phase angle of the sensor signal as a function of frequency. The instrument/control electronics 126 interpret these changes to detect the presence of the targeted analyte. In some embodiments, the instrument/control electronics also determines, for example, the concentration of the targeted analyte on the inner surface of themembrane 134. - Capture agents targeting the analyte of interest are immobilized on the thin layer of
gold 140 covering the inner surface of themembrane 134, as described above. Thiol-terminated alkyl chains are linked to the gold surface forming a self-assembled monolayer (SAM). A fraction of the SAM chains are terminated with reactive groups (e.g, carboxyl) to allow covalent linking of capture agents to the SAM chains using biochemical process steps known in the art. The remainder of the SAM chains are terminated with non-reactive groups, preferably ones that have a hydrophilic character to resist nonspecific binding (e.g., oligomers of ethylene glycol). Other surface chemistries are described in the literature and can be used to produce a capture surface. - The
FPW device 104 is packaged to allow electrical connections to theelectrodes 138 on the outer surface of themembrane 134. Additionally, theFPW device 104 is mechanically supported by achannel block 142, to allow for the inner surface of themembrane 134 to contact the test solutions and an interface is provided for contacting thesensor surface 143 with the liquid sample. Thechannel block 142 creates a path (fluid chamber 160) for the test solutions to flow from aninput port 118, past the inner surface of themembrane 134 and then out of anexit port 120. Aseal 144 is formed between theFPW device 104 and thechannel block 142 to prevent test solutions from escaping from thechannels 102 formed within the combination of theFPW device 104 and thechannel block 142. Thechannel block 142 thus forms a fluid chamber, of which theFPW device 104 comprises one of the interior walls. - The
channels 102 through the combination of theFPW device 104 and thechannel block 142 are approximately 0.5 mm in diameter. Thechannel block 142 can be formed from a variety of materials, including plastic, metal or ceramic, among other materials. - The
system 100 includes one or more fluid control devices for changing at least one fluid property, such as flow, pressure, or trajectory to name a few, within thesystem 100. Thepump 122 andvalves 114 shown inFIG. 1A that direct and control the flows of various test solutions through the device and over the sensor surface 143 (as required to execute a test protocol) are all examples of fluid control devices. In general, a fluid control device changes the at least one fluid property in the vicinity of at least one surface within thefluid chamber 160 of thedevice 104. Generally, this is done to distribute the magnetic particles along at least a portion of thesensor surface 143. As described above, in some embodiments the fluid control device is a pump (e.g., a peristaltic pump, centrifugal pump, rotary pump, electro-osmotic pump). In some embodiments, the pump is located on the entrance side of the fluid chamber, and in other embodiments the pump is located on the exit side of the fluid chamber. In some embodiments, the device is a flow diverter (e.g., a plug, obstruction wall or baffle) that is disposed relative to the fluid chamber to alter the fluid flow in the vicinity of the at least one interior surface of the fluid chamber. - Referring to
FIG. 1A , asingle pump 122 is positioned on the waste side of theFPW device 104. Suction that thepump 122 generates draws buffer 110 or analyte in thesample 108 from theirrespective reservoir containers 112 on the supply side of theFPW device 104.Valves 114 are positioned on the supply side of thedevice 104 to control which test solution is directed over thesensor surface 143 at any time during the test protocol. Thepump 122 controls the flow rate of the test. - A device for regulating temperature (e.g., a thermoelectric cooler) may be associated with the
FPW device 104 andchannel block 142. This reduces the impact of variable environmental conditions on theFPW device 104 output by maintaining thedevice 104 at a relatively constant, known temperature. In an alternative embodiment, a temperature sensor is included within thesystem 100, for example as part of theFPW device 104. The sensor signal from theFPW device 104 is scaled, at a specific instant in time (or during a period of time), based on the output of the temperature sensor, in order to produce a signal that is independent of the effects of temperature variations. This scaling could be done based on a mathematical model, or an analytical model, or some hybrid combination of a mathematical and analytical model. - In some embodiments of the
system 100, a filter is included in the path of the test solution to selectively filter particles (e.g., magnetic particles and biological materials) of a particular size to prevent them from entering the fluid chamber. By way of example, a particular testing protocol may include steps for changing the filter during the test. This would allow different types (i.e., sizes) of analytes and magnetic particles to be directed into the fluid chamber, and thereby tested by thesystem 100, during different portions of the test. - Magnetic particles (e.g., paramagnetic or super-paramagnetic beads or microspheres), which have their surfaces coated with a capture agent, are mixed with a sample containing the analyte. After a prescribed mixing time analyte-
particle complexes 146 result as doparticles 147 that have bound nonspecific materials andparticles 148 that have bound nothing. Theparticles sample reservoir 112. - The
system 100 further includes a magneticfield inducing structure 150 for producing magnetic flux in the vicinity of themembrane 134. InFIG. 1A , the source of magnetic flux is aretractable magnet 150 arranged to normally be in close proximity to themembrane 134 of theFPW device 104. When themagnet 150 is in close proximity to themembrane 134, themagnet 150 produces a significant gradient magnetic field in the vicinity of themembrane 134. Under control of the instrument/control electronics 126, theretractable magnet 150 can be retracted away from themembrane 134 by a distance sufficient to substantially reduce magnetic fields in the vicinity of themembrane 134. In one embodiment, when in close proximity to themembrane 134, themagnet 150 is situated approximately 200 μm from thesensor surface 143 of themembrane 134. In another embodiment, when in close proximity to the membrane, themagnet 150 is situated between about 50 μm to about 100 μm from thesensor surface 143 of themembrane 134. - When the
magnet 150 is in close proximity to themembrane 134, themagnet 150 provides a source of magnetic flux to draw the magnetic particles from the sample to thesensor surface 143. The analyte-particle complexes 146, as well asparticles 147 with nonspecifically bound material andparticles 148 with nothing bound, migrate from the liquid sample until they encounter thesensor surface 143. The analyte binds with the capture agent on thesensor surface 143. Thus, the analyte forms a link between the magnetic particle and sensor surface. Theparticles 147 with non-specially bound material andparticles 148 with nothing bound are held at thesensor surface 143 by the magnetic field. Additionally, weak binding forces can act between theparticles sensor surface 143. During the wash step of the protocol (described in more detail below), themagnet 150 is retracted to reduce the magnetic force experienced by the particles that have accumulated at thesensor surface 143. The wash flow rate is increased to removeparticles particles 147 with nonspecifically bound material as well asparticles 148 with nothing bound are more weakly linked to thesensor surface 143 than the analyte-particle complexes 146, they release from thesensor surface 143 at a lower wash flowrate (and corresponding hydrodynamic force). Hence, removing the magnet 150 (i.e., substantially reducing the magnetic force experienced by theparticles analyte 146 from those without (particles 147 and 148). One technique for engaging and retracting themagnet 150 is to mount it on a carriage (not shown) that is actuated by a cam system (not shown). - The
magnet 150 material, geometry and distance from thesensor surface 143 determine the field shape and field gradient, and therefore, the force that the analyte-particle complexes 146 experience. High strength permanent magnets for use as theretractable magnet 150 are available commercially. For example, 1 mm diameter cylindrical NdFeB magnets can be purchased from several vendors (e.g., Dexter Magnetic Technologies). In one embodiment, a 1 mm diameter and 5 mmlong NdFeB magnet 150 is positioned within 0.1 mm of thesensor surface 143 when engaged. When retracted themagnet 150 is at least 0.5 mm from thesensor surface 143. Since themembrane 134 of theFPW device 104 is very thin (2 μm) and made of nonmagnetic materials (e.g., silicon, aluminum nitride or gold), themembrane 134 does not significantly perturb the magnetic field on thesensor surface 143 side of thedevice 104. As a result, very high magnitude magnetic fields and large field gradients can be achieved, as is necessary for high collection efficiencies. - The sample flow rate through the
channels 102 is determined (e.g., specified by an operator) by the residence time necessary for good collection efficiency. The sample flow rate is adjusted so that the average velocity over thesensor surface 143 is between about 1 and about 5 mm/s. With an iron oxide paramagnetic particle with a diameter of approximately 3 μm, collection efficiencies approaching 50% can be achieved. - Other configurations of the
source 150 of magnetic flux (i.e., the magnet) may be used. For example, an electromagnet can be used instead of a permanent magnet. The electromagnet includes pole pieces that extend to focus the field flux near thesensor surface 143 of thedevice 104. - Alternatively, a magnetizable material can be fashioned and positioned adjacent to the sensor surface 143 (within 0.1 mm), and a separate magnet combined with an open face of the magnetizable material to induce a magnetic field in the magnetizable material. The magnetic field induced in the material serves to locate desirable field gradients near the sensor surfaces 143. In this way, large, low cost magnets can be used, and a single magnet can be used to address multiple sensors, depending on the fashioning of the material. Examples of useful materials for this purpose are pure iron, high mu metals such as alloy 49 (high nickel content iron), sna silicon steels (1-2% silicon typical). An advantage of using such a magnetizable material with an associated magnet is that the sensor assembly can be simplified, allowing lower cost manufacturing. A low precision actuator can be used for engaging and retracting the magnet since the magnet need only contact the ferromagnetic core or be fully withdrawn. In the described embodiment where the
magnet 150 is positioned in close proximity to thesensor surface 143, a higher level of precision is required to achieve good assay repeatability. Although there is some loss of field strength with this approach, it is still possible to design the overall system to achieve good capture efficiencies (e.g., >10%). - The shape of the tip of the field inducing structure (e.g., magnet or ferromagnetic material) may be tailored to enhance and/or concentrate the field gradient at the surface. Since the size of the FPW device 104 (e.g., 0.3 mm×1.6 mm) is typically smaller than conventionally formed magnets or machined inductors, the portion of the field inducing structure adjacent to the
membrane 134 can be tapered to concentrate the magnetic field in one or more locations on thesensor surface 143. Tapering the tip acts to increase both the local field magnitude and the local field gradients. For example, a wedge-shaped tip is well suited to the current FPW device geometry. - One embodiment of the
system 100 includes an optionalsecond source 150 a of magnetic flux that opposes or partially opposes thefirst source 150 of magnetic flux. Thissecond source 150 a of magnetic flux can be used to dislodge some of the magnetic particles that have adhered to thesensor surface 143. It may, for example, dislodgemagnetic particles 148 that do not have any bound analyte; they would not be as strongly attached to thesensor surface 143 as theparticles 146 that do have bound analyte. In some embodiments, thefirst source 150 of magnetic flux is turned off or moved away from thesensor surface 143 and then, thesecond source 150 a of magnetic flux is positioned relative to the at least one surface of the fluid chamber to selectively remove magnetic particles. This may be done, for example, to removemagnetic particles 148 that do not have any bound analyte and therefore they are not as strongly bound to thesensor surface 143. This would achieve a similar effect as increasing the flow of fluid to removemagnetic particles 148 that do not have any bound analyte. - Controlling the distribution of the analyte-
particle complexes 146 on thesurface 143 of thedevice 104 can improve the device performance, since thedevice 104 has a suspendedmembrane 134 and not all parts of themembrane 134 contribute equally to the moving mass of the detectable resonance. For example, thesystem 100 can be constructed and arranged to distribute the analyte-particle complexes 146 within one third of theFPW device 104 width along the middle two-thirds of the centerline of the long axis of themembrane 134. Taking into account flow field effects, the shape of the tip of the field-inducing structure (e.g., magnet 150) can be such that the field magnitude and field gradient increase in the direction of the flow over thesensor membrane 134. That is, analyte-particle complexes 146 in the downstream regions, where the boundary layer is partially depleted of analyte, experience a higher field and field gradient than do analyte-particle complexes 146 in the upstream regions. - In general, the
system 100 can be constructed and arranged to concentrate magnetic particles in one or more particular regions of thesensor surface 143. The response of thedevice 104 may not be uniform over thesensor surface 143 due to characteristics of the fabrication materials or the specifics of the sensor design. Thus, high sensitivity regions of thedevice 104 may be non-uniform and asymmetrical with respect to the long and short axis centerlines of thedevice 104. Thus, the tip of the field inducing structure may be shaped to concentrate magnetic particles in the region or regions of highest sensitivity. - Varying the flow rate through the
device 104 can also be used to achieve a more uniform coverage of analyte-particle complexes 146 for a given magnetic field distribution. For a given field, magnetic particles interact with thesensor surface 143 as determined by the bulk fluid flow rate, much like a ballistic object might fall in the presence of the gravity body force. In this case, however, the magnetic induced force dominates. By varying the flow rate, the analyte-particle complexes 146 can be caused to interact with thesensor surface 143 at substantially different locations along the stream-wise flow direction. Furthermore, as the magnetic particles pile up (a non-desirable occurrence if they are to be exposed to the sensor surface 143) the flow can be reversed and subsequently pulsed forward in order to pull the pile over and thus communicate more particles with thesensor surface 143. In one embodiment of thesystem 100, selective location of the magnetic particles along thesensor surface 143 is achieved by selectively altering, over the course of the detection protocol, either one or both of the magnetic flux source and the property or properties of the fluid flow along thesensor surface 143. - One embodiment of the
system 100 includes a device (e.g., optical, magnetic) for characterizing at least one property of the magnetic particles that are attached or attracted to thesensor surface 143. This device could be an integral part of theFPW device 104, or it could be a part of themagnet 150, or it could be a discrete component apart from other components of thesystem 100. Such a device may be used to detect the presence of the particles, and also to determine parameters related to the particle, for example, the size, quantity, concentration, or density of the particles that are attracted to thesensor surface 143. - One embodiment of the
system 100 includes an identification device for allowing an operator or computer to identify thesystem 100 or a particular component of the system for tracking usage of the system or component. The identification device may include a symbol or image such as a bar code, an identification number, or other identifying mark. The identification device may include an actual component, passive or active, such as an RFID tag, an integrated circuit or other such component known in the art for providing identifying information. Many such devices are known in the art, although any contemplated identification device may be used. - A
general detection protocol 200 for using anFPW device 104 in combination with analyte-particle complexes 146 for detection of biological analytes is shown inFIG. 3 . - The
first step 202 of thedetection protocol 200 is acquiring and preparing 202 the analyte sample. Various preparation processes may need to be performed prior to testing, depending upon the particular type of analyte being tested. For example, to detect microbes in food (e.g., E. coli in ground beef), a sample would be first mixed with enrichment broth, stomached, incubated and filtered. For detecting proteins in blood, the sample would first be filtered or centrifuged and the serum separated. Specific examples of test protocols that include sample preparation steps are described herein. - The
next step 204 of the detection process is mixing affinity-coated paramagnetic particles (i.e., beads) with the prepared analyte sample. Paramagnetic or super-paramagnetic particles are available commercially from a number of vendors (e.g., Dynal Biotech, Oslo, Norway). Typical diameters range from 50 nm to 10 μm, and such particles can be procured already coated with affinity agents (e.g., antibodies, proteins, and nucleic acid probes) targeting a variety of analytes (e.g., cells, proteins and nucleic acids). Alternatively, the particles can be purchased with various reactive chemical groups (e.g., epoxy, carboxyl, and amine) in order to attach a capture agent of choice. Standard biochemical protocols are available for this purpose. - The sample with paramagnetic particles added is agitated 206 for an amount of time determined by the particular analyte and capture agent. During this process, the particles bind with analyte so that the analyte is captured on the particles. In some cases, the sample can be tested directly at this point. But, in other cases it is advantageous to perform
separation steps 208 to isolate the analyte bound to the particles from the rest of the original sample. These separation steps 208 reduce interference from other biological material in the assay. Manual or automated equipment for performing such separation steps is available commercially (e.g., Dexter Magnetic Technologies, Dynal Biotech). The basic process uses a magnet to localize the paramagnetic particles on a surface so that the majority of the sample liquid can be aspirated. The magnet (e.g.,magnet 150 ofFIG. 1A ) is then removed, and clean buffer solution is added to re-suspend the particles. - A
baseline step 210 is executed prior to testing the processed analyte sample with theFPW device 104. During thebaseline step 210, areference solution 106 is flowed through the system to rinse/block thesensor 104, and the instrument/control electronics 126 excite thedevice 104 and records the resulting initial baseline signal from thedevice 104. - A
sample transport step 212 follows thebaseline step 210. Thesample 108 containing the analyte-particle complexes 146 is flowed over thesensor surface 143 with themagnet 150 engaged. Analyte-particle complexes 146 are collected on thesensor surface 143. After a prescribed volume ofsample 108 has flowed through thedevice 104, themagnet 150 is retracted to release theparticles sensor surface 143 that do not have bound analyte, and the flow is switched to a wash solution (e.g., buffer solution 110). The flow rate of the wash solution is increased to help remove loosely boundparticles sensor surface 143 - An
acquisition step 214 follows thesample transport step 212.Reference solution 106 is again run through thedevice 104, and the instrument/control electronics 126 excite thedevice 104 to acquire and record a final baseline signal from thedevice 104. - The
system 100 determines the amount of analyte accumulated on thesensor surface 143 during thetransport step 212 by comparing 216 the initial baseline signal and the final baseline signal, which correspond to the vibrational characteristics of theFPW device 104 in the reference solution before and after, respectively, theacquisition step 214. Analyte-particle complexes 146 bound to thesensor surface 143 change the vibrational characteristics of theFPW device 104, and the amount of change to the vibrational characteristics correspond to the amount of anaylyte-particle complexes bound to thesensor surface 143. -
FIG. 4 shows the change in the signal frommultiple FPW devices 104 as a function of time for an exemplary detection protocol. The square symbols correspond to adevice 104 exposed to an analyte; the triangles and stars correspond to negative controls (in which there is no analyte on the beads). The data shown inFIG. 4 (andFIG. 5 as described below) represent an exemplary detection protocol for which the analyte is E. coli bacteria, or generally a cellular analyte. - In this particular experiment, the frequency of a resonant peak was tracked.
FIG. 4 shows that the resonant frequency of theFPW device 104 decreases as themagnetic particles magnet 150 is removed and some of the magnetic particles are washed away, the frequency of thedevice 104 increases. Eventually, the system establishes a final baseline that can be compared to the initial baseline taken at the start of the test, or to that of a control. -
FIG. 5 is a summary plot showing the final signal change detected as a function of original analyte concentration. - Other detection protocols may be used with the
system 100 described above. Individual steps can be eliminated or added depending on the requirements of a specific application or analyte. For example,FIG. 6 shows a time evolution plot for a detection protocol, similar to the one shown inFIG. 4 .FIG. 6 , however, depicts a detection protocol for a PSA assay, which demonstrates the capability of thesystem 100 for detecting proteins. Also, the flow direction can be reversed during the protocol. For example, reversing the flow direction may be useful for washing nonspecifically bound material from the device, or for making more efficient use of the available sample. - Another variation in the detection protocol includes alternating between wash steps and binding steps. This can allow better use of the dynamic range of the device. In come cases, a large fraction of the particles do not have bound analyte, especially at low analyte concentrations. By repeatedly binding and washing away particles, it is possible to accumulate more analyte-
particle complexes 146 and, hence, improve the sensitivity of the measurement. - Changing or manipulating the magnetic field distribution at the
sensor surface 143 during thetransport step 212 can enhance the probability that the analyte attached to a particular particle encounters thesensor surface 143. For example, if the spatial distribution of the field is alternated during binding, it is possible to cause the paramagnetic particles at thesensor surface 143 to roll. In some embodiments, by controlling the spatial distribution of the field, an operator or the instrument/control electronics 126 can be used to control the rolling of the paramagnetic particles along thesensor surface 143. - As described above, introducing a second magnetic field (i.e., a second source of magnetic flux) in the
system 100 can improve the control of the assay conditions and enhance the specificity of the assay. For example, during the binding or wash steps of the protocol as described above, applying a secondary magnetic field to thesensor surface 143 can act to pull off weakly bound magnetic particles. The strength of the secondary field can be tailored to generate a force on the analyte-particle complexes 146 at thesensor surface 143 that is below the binding force of the specifically bound analyte but above the typical binding force for nonspecifically bound material. This sequence of steps can be repeated multiple times during the assay to further increase the specificity of the test. - The relative binding strength of the various analyte-
particle complexes 146 on thesensor surface 143 can be determined by increasing (continuously or discretely) this magnetic pull-off force during the wash step, while monitoring the response of theFPW device 104. Information on the relative binding strength can be used to distinguish between different analytes in thesample 108. - The particular way the sample interfaces with the
device 104 can be different in other embodiments. In the above-described embodiments, thesystem 100 flows the sample through a channel to establish contact between the analyte-particle complexes 146 and thesensor surface 143. In an alternative variation of thesystem 100, theFPW device 104 is mounted on a probe and at least partially immersed into a test solution containing magnetic particles bound to an analyte. For this embodiment, the immersion is sufficient to place the bound magnetic particles in proximity to thesensor surface 143 so that the particles are attracted toward thesensor surface 143 and subsequently detected, as described herein. To obtain a baseline signal, the device 104 (or cartridge 103) is immersed in a reference test solution. In some embodiments, a portion of the device 104 (e.g., the membrane 134) is mounted to a probe. Further, only part of thesensor surface 143 of themembrane 134 is placed in contact with the solution containing magnetic particles bound to an analyte. In these embodiments, immersion or controlled movement of the probe in the fluid is sufficient to place the bound magnetic particles in proximity to thesensor surface 143 so that the particles are attracted toward thesensor surface 143 and subsequently detected. - Another alternative embodiment of the
system 100 involves mounting thedevice 104 inside of a tube that can be partially immersed into a well holding thesample 108, and then retracted. A pump applies suction to draw sample into the tube and over the sensor surface 143 (or cartridge 103) when the sample is immersed. The sample is then ejected back into the well by reversing the pump or simply by venting the tube. This cycle of drawing and releasing the sample can be repeated to improve the collection efficiency and, therefore, the performance of the assay. - The following examples illustrate, for one embodiment of the
system 100 described herein, steps for preparing and utilizing thesystem 100 for detecting an analyte. - A. Generalized Method for Capture Agent Functionalization of a Surface of a Flexural Plate Wave Device
-
- 1. Deposit gold onto the surface (e.g., sensor surface 143) of the flexural
plate wave device 104 and clean thegold surface 143 with, for example, oxygen plasma. - 2. An ideal surface chemistry for the
surface 143 of the gold is one that provides 1) non-specific binding resistance and 2) reactive groups located on the surface for covalent attachment of capture agents. An exemplary surface chemistry for thesurface 143 of the gold is a self-assembled monolayer (SAM) of alkane thiols. The SAM can be formed from a mixture of two alkane thiols; one terminated with a reactive group for subsequent covalent attachment of capture agents, and one terminated with a non-reactive group. By way of example, a mixture of EG3-OH (EG3) and EG6-OCH2COOH (EG6) terminated C11-alkane thiols may be used for this purpose. In one embodiment, the flexural plate wave device 104 (particularly thesurface 143 of the device 104) is placed in contact with the alkane thiol solution and allowed to incubate at room temperature for, for example, about 16 hours. Thesurface 143 of the flexuralplate wave device 104 is then rinsed with ethanol and blown dry with nitrogen. - 3. The next step involves covalent attachment of capture agent to the
surface 143 of the flexuralplate wave device 104. A number of methods may be used for covalent attachment of capture agent. An exemplary method involves covalently linking a biotin linker moiety to the SAM, then binding a biotinylated antibody to the flexural platewave device surface 143 via a streptavidin linking layer. - 4. After biotinylating the
surface 143 of the flexuralplate wave device 104, thedevice 104 is functionalized with specific capture agents through a neutravidin-binding layer. The functionalization is accomplished by sequentially exposing thesurface 143 of the biotinylated flexuralplate wave device 104 to a concentrated neutravidin solution and then to a solution of the biotinylated capture agent of choice.
- 1. Deposit gold onto the surface (e.g., sensor surface 143) of the flexural
- B. Detecting E. coli 0157:H7 In Ground Beef Using, for Example, the Method of
FIG. 3 (FIG. 5 Contains Data Representative of Various Concentrations of E. coli). -
- 1. Prepare an analyte sample containing E. coli O157:H7 with a concentration greater than about 100 cfu/mL.
- 2. Concentrate the analyte sample in solution by performing an immunomagnetic separation. A variety of commercial instruments (e.g., PATHATRIX™ antibody coated paramagnetic particles by Matrix Microsciences and the BEADRETRIEVER™ magnetic bead processor by Dynal Biotech) or manual methods may be used to perform the immunomagnetic separation. An exemplary manual method involves:
- a. Resuspend magnetic beads coated with E. coli antibody (e.g., Dynabeads anti-E. coli 0157, available from Dynal Biotech) until the magnetic bead pellet in the bottom of the tube disappears. Place a microcentrifuge tube in the rack (e.g., a Dynal MPC-S) of a magnetic plate. Pipette 1-20 μL of magnetic bead stock solution into the tube (the volume of magnetic bead stock selected is based on desired final bead concentration).
- b. Add 1 mL of the analyte sample to the tube in the rack of the magnetic plate and close the tube.
- c. Invert the rack a few times. Incubate the solution in the tube at room temperature for 10 to 60 minutes with gentle continuous agitation to prevent magnetic beads from settling.
- d. Invert the rack several times to concentrate the magnetic beads into a pellet on the side of the tube. Allow about 3 minutes for proper recovery.
- e. Open the tube and carefully aspirate and discard the sample supernatant as well as the remaining liquid in the tube's cap.
- f. Remove the magnetic plate.
- g. Add 1 mL of wash buffer (PBS-TWEEN® 20 (polyoxyethylene glycol sorbitan monolaurate)—Sigma-Aldrich Co. with offices in St. Louis, Mo.) to the tube. Close the cap of the tube and invert the rack a few times to resuspend the beads.
- h. Repeat steps d-g twice.
- i. Mix the contents of the tube briefly using a vortex mixer.
- 3. Detection of E. coli O157:H7
- a. Functionalize (similarly as described by the steps in A.3 and A.4) the
surface 143 of a flexuralplate wave device 104 with E. coli O157:H7 antibody. - b. Place a first inlet hose into a tube containing standard wash buffer (1×PBS with 0.05% TWEEN® 20 (polyoxyethylene glycol sorbitan monolaurate)—Sigma-Aldrich Co. with offices in St. Louis, Mo.) and a second inlet hose into the tube containing the magnetic beads bound with E. coli O157:H7 (prepared in B.2). The first inlet hose and second inlet hose are joined by a t-joint so the two hoses are in fluid communication and fluid from either the first inlet hose or from the second inlet hose is directed to an inlet of the
fluid chamber 160. Each of the two hoses has a valve that is capable of permitting or limiting the flow of fluid through respective hoses. - c. Place a first outlet hose in fluid communication with an outlet of the
fluid chamber 160. Fluid from the first outlet hose is collected in a waste collection bottle. - d. A baseline output signal is obtained using the flexural plate wave device. The baseline signal is measured with standard wash buffer flowing into the
fluid chamber 160 and out of thefluid chamber 160 for about 5 minutes at a standard pump speed (e.g., 200 μL/min). - e. The first source of
magnetic flux 150 is engaged, and then fluid from the tube containing the analyte is directed into the inlet of thefluid chamber 160. Fluid is directed into the inlet of thefluid chamber 160 to accumulate magnetic beads bound with E. coli O157:H7 on the at least onesurface 143 of the flexuralplate wave device 160 until a desired amount is attached to the at least onesurface 143. In one embodiment, the desired amount is achieved when, for example, there is a frequency shift in the output of the flexuralplate wave device 104 of about 4000 ppm. - f. The flow of fluid from the tube containing the analyte is then discontinued. Fluid from the wash buffer tube is then directed into the
fluid chamber 160 to wash away nonspecifically bound material (i.e., materials other than 1) magnetic beads and 2) magnetic beads with bound analyte). - g. The first source of
magnetic flux 150 is then disengaged. - h. Initiate automatic wash protocol to remove any magnetic beads or matrix components.
- i. The final signal output by the flexural
wave plate device 104 is then measured. The baseline signal is compared with the final signal to determine the concentration of E. coli O157:H7 in the analyte sample.
- a. Functionalize (similarly as described by the steps in A.3 and A.4) the
- C. Detecting Prostate Specific Antigen (PSA) in Human Blood Serum Using, for Example, the Method Steps of
FIG. 3 . -
- 1. Prepare an analyte sample containing human serum obtained by centrifugation from a human blood sample.
- 2. Concentrate the analyte sample in solution by performing an immunomagnetic separation. A variety of commercial instruments (e.g., PATHATRIX™ antibody coated paramagnetic particles by Matrix Microsciences and the BEADRETRIEVER™ magnetic bead processor by Dynal Biotech) or manual methods may be used to perform the immunomagnetic separation. An exemplary manual method involves:
- a. Resuspend magnetic beads coated with PSA antibody (e.g., Dynabeads anti-PSA, available from Dynal Biotech) until the magnetic bead pellet in the bottom of the tube disappears. Place a microcentrifuge tube in the rack (e.g., a Dynal MPC-S) of a magnetic plate. Pipette 1-20 μL of magnetic bead stock solution into the tube (the volume of magnetic bead stock selected is based on desired final bead concentration).
- b. Add 1 mL of the analyte sample to the tube in the rack of the magnetic plate and close the tube.
- c. Invert the rack a few times. Incubate the solution in the tube at room temperature for 10 to 60 minutes with gentle continuous agitation to prevent magnetic beads from settling.
- d. Invert the rack several times to concentrate the magnetic beads into a pellet on the side of the tube. Allow about 3 minutes for proper recovery.
- e. Open the tube and carefully aspirate and discard the sample supernatant as well as the remaining liquid in the tube's cap.
- f. Remove the magnetic plate.
- g. Add 1 mL of wash buffer (PBS-TWEEN® 20 (polyoxyethylene glycol sorbitan monolaurate)—Sigma-Aldrich Co. with offices in St. Louis, Mo.) to the tube. Close the cap of the tube and invert the rack a few times to resuspend the beads.
- h. Repeat steps d-g twice.
- i. Mix the contents of the tube briefly using a vortex mixer.
- 3. Detection of PSA
- a. Functionalize (similarly as described by the steps in A.3 and A.4) the
surface 143 of a flexuralplate wave device 104 with PSA antibody. - b. Place a first inlet hose into a tube containing standard wash buffer (1×PBS with 0.05% TWEEN® 20 (polyoxyethylene glycol sorbitan monolaurate)—Sigma-Aldrich Co. with offices in St. Louis, Mo. and a second inlet hose into the tube containing the magnetic beads bound with PSA (prepared in B.2). The first inlet hose and second inlet hose are joined by a t-joint so the two hoses are in fluid communication and fluid from either the first inlet hose or from the second inlet hose is directed to an inlet of the
fluid chamber 160. Each of the two hoses has a valve that is capable of permitting or limiting the flow of fluid through respective hoses. - c. Place a first outlet hose in fluid communication with an outlet of the
fluid chamber 160. Fluid from the first outlet hose is collected in a waste collection bottle. - d. A baseline output signal is obtained using the flexural
plate wave device 104. The baseline signal is measured with standard wash buffer flowing into thefluid chamber 160 and out of thefluid chamber 160 for about 5 minutes at a standard pump speed (e.g., 200 μL/min). - e. The first source of
magnetic flux 150 is engaged, and then fluid from the tube containing the analyte is directed into the inlet of thefluid chamber 160. Fluid is directed into the inlet of thefluid chamber 160 to accumulate magnetic beads bound with PSA on the at least onesurface 143 of the flexuralplate wave device 104 until a desired amount is attached to the at least onesurface 143. In one embodiment, the desired amount is achieved when, for example, there is a frequency shift in the output of the flexuralplate wave device 104 of about 4000 ppm. - f. The flow of fluid from the tube containing the analyte is then discontinued. Fluid from the wash buffer tube is then directed into the
fluid chamber 160 to wash away nonspecifically bound material (i.e., materials other than 1) magnetic beads and 2) magnetic beads with bound analyte). - g. The first source of
magnetic flux 150 is then disengaged. - h. Initiate automatic wash protocol to remove any magnetic beads or matrix components.
- i. The final signal output by the flexural
wave plate device 104 is then measured. The baseline signal is compared with the final signal to determine the concentration of PSA in the analyte sample.
- a. Functionalize (similarly as described by the steps in A.3 and A.4) the
- The invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The present embodiments are therefore to be considered in respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of the equivalency of the claims are therefore intended to be embraced therein.
Claims (19)
1-21. (canceled)
22. A method for detection of an analyte, comprising:
combining a fluid containing an analyte with a plurality of magnetic particles that comprise a capture agent having an affinity for the analyte to produce at least some magnetic particles bound to at least some analyte;
directing the combined fluid into a first fluid chamber, wherein at least one surface of a flexural plate wave device is in fluid communication with the fluid in the first fluid chamber; and
creating a first magnetic flux in proximity to the flexural plate wave device to magnetically attract at least some of the plurality of bound magnetic particles to the at least one surface of the flexural plate wave device.
23. The method of claim 22 , further comprising selectively altering at least one of the first magnetic flux in proximity to the at least one surface of the flexural plate wave device or altering at least one property of fluid flow in proximity to the at least one surface of the flexural plate wave device to selectively locate at least some of the plurality of bound magnetic particles on at least a portion of the at least one surface of the flexural plate wave device.
24. The method of claim 23 wherein the at least one property of the fluid flow is selected from the group consisting of fluid pressure, flow rate, and fluid trajectory.
25. The method of claim 23 wherein altering the at least one property of fluid flow comprises altering a flow path of the fluid to control the movement of the magnetic particles in vicinity to the at least one surface of the flexural plate wave device.
26. The method of claim 22 , further comprising applying a second magnetic flux in opposition to the first magnetic flux.
27. The method of claim 26 , further comprising changing the second magnetic flux to selectively dislodge at least some of the magnetic particles not bound to analyte from the at least one surface of the flexural plate wave device.
28. The method of claim 22 , further comprising terminating the first magnetic flux and creating a second magnetic flux to selectively remove some of the magnetic particles from the at least one surface of the flexural plate wave device.
29. The method of claim 22 , further comprising exciting the flexural plate wave device to selectively dislodge materials adhering to the at least one surface of the flexural plate wave device.
30. The method of claim 22 , further comprising characterizing a property of the magnetic particles attracted to the at least one interior surface.
31. The method of claim 22 , further comprising filtering the combined fluid prior to directing the combined fluid into the first fluid chamber.
32. The method of claim 22 wherein directing the combined fluid into the first fluid chamber comprises pumping the combined fluid into a first opening of the first fluid chamber and out of a second opening in the first fluid chamber.
33. The method of claim 22 wherein directing the combined fluid into the first fluid chamber comprises flowing the combined fluid into a first opening of the first fluid chamber.
34. The method of claim 22 wherein first fluid chamber is located in a cartridge and the fluid containing the analyte and at least some of the plurality of magnetic particles that comprise the capture agent are combined in a second fluid chamber of the cartridge prior to directing the combined fluid into the first fluid chamber.
35. The method of claim 22 , further comprising directing at least a portion of the combined fluid out of an opening in the first fluid chamber.
36. The method of claim 22 wherein directing the combined fluid into the first fluid chamber comprises immersing a cartridge comprising the first fluid chamber into a vessel containing the combined fluid.
37. The method of claim 22 , further comprising selectively altering at least one of the first magnetic flux in proximity to the at least one surface of the flexural plate wave device or altering at least one property of fluid flow in proximity to the at least one surface of the flexural plate wave device to selectively remove from the first fluid chamber, substances located within the combined fluid.
38. The method of claim 37 wherein the substances are selected from the group consisting of magnetic particles, analyte, bound magnetic particles, and combinations thereof.
39-43. (canceled)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/709,068 US20070281371A1 (en) | 2005-05-02 | 2007-02-21 | Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67675905P | 2005-05-02 | 2005-05-02 | |
US69059205P | 2005-06-15 | 2005-06-15 | |
US11/183,484 US7300631B2 (en) | 2005-05-02 | 2005-07-18 | Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles |
US11/709,068 US20070281371A1 (en) | 2005-05-02 | 2007-02-21 | Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/183,484 Division US7300631B2 (en) | 2005-05-02 | 2005-07-18 | Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070281371A1 true US20070281371A1 (en) | 2007-12-06 |
Family
ID=37308639
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/183,484 Active 2025-11-16 US7300631B2 (en) | 2005-05-02 | 2005-07-18 | Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles |
US11/417,005 Expired - Fee Related US7598094B2 (en) | 2005-05-02 | 2006-05-02 | Methods and apparatus for detecting cardiac injury markers using an acoustic device |
US11/416,998 Expired - Fee Related US7629137B2 (en) | 2005-05-02 | 2006-05-02 | Methods and apparatus for detecting bacteria using an acoustic device |
US11/417,000 Expired - Fee Related US7615381B2 (en) | 2005-05-02 | 2006-05-02 | Method and apparatus for detecting estradiol and metabolites thereof using an acoustic device |
US11/416,997 Expired - Fee Related US7632638B2 (en) | 2005-05-02 | 2006-05-02 | Methods and apparatus for detecting viruses using an acoustic device |
US11/709,068 Abandoned US20070281371A1 (en) | 2005-05-02 | 2007-02-21 | Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/183,484 Active 2025-11-16 US7300631B2 (en) | 2005-05-02 | 2005-07-18 | Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles |
US11/417,005 Expired - Fee Related US7598094B2 (en) | 2005-05-02 | 2006-05-02 | Methods and apparatus for detecting cardiac injury markers using an acoustic device |
US11/416,998 Expired - Fee Related US7629137B2 (en) | 2005-05-02 | 2006-05-02 | Methods and apparatus for detecting bacteria using an acoustic device |
US11/417,000 Expired - Fee Related US7615381B2 (en) | 2005-05-02 | 2006-05-02 | Method and apparatus for detecting estradiol and metabolites thereof using an acoustic device |
US11/416,997 Expired - Fee Related US7632638B2 (en) | 2005-05-02 | 2006-05-02 | Methods and apparatus for detecting viruses using an acoustic device |
Country Status (5)
Country | Link |
---|---|
US (6) | US7300631B2 (en) |
EP (2) | EP1891441B1 (en) |
JP (3) | JP2008541052A (en) |
KR (2) | KR101257527B1 (en) |
WO (2) | WO2007030155A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010087985A2 (en) | 2009-01-28 | 2010-08-05 | Yale University | Novel markers for detection of complications resulting from in utero encounters |
US8435463B2 (en) | 2006-11-21 | 2013-05-07 | Bioscale, Inc. | Method and apparatus for analyte processing |
WO2013158045A1 (en) * | 2012-04-20 | 2013-10-24 | Agency For Science, Technology And Research | Microfilter and apparatus for separating a biological entity from a sample volume |
US20140340681A1 (en) * | 2013-05-17 | 2014-11-20 | Azbil Corporation | Particle detecting device and particle detecting method |
Families Citing this family (147)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048734A (en) | 1995-09-15 | 2000-04-11 | The Regents Of The University Of Michigan | Thermal microvalves in a fluid flow method |
US6692700B2 (en) | 2001-02-14 | 2004-02-17 | Handylab, Inc. | Heat-reduction methods and systems related to microfluidic devices |
US7323140B2 (en) | 2001-03-28 | 2008-01-29 | Handylab, Inc. | Moving microdroplets in a microfluidic device |
US7829025B2 (en) | 2001-03-28 | 2010-11-09 | Venture Lending & Leasing Iv, Inc. | Systems and methods for thermal actuation of microfluidic devices |
EP1654066B1 (en) | 2003-07-31 | 2014-11-12 | Handylab, Inc. | Processing particle-containing samples |
US20090288479A1 (en) * | 2003-11-17 | 2009-11-26 | Woody Shane C | Standing wave fluidic and biological tools |
US8470586B2 (en) | 2004-05-03 | 2013-06-25 | Handylab, Inc. | Processing polynucleotide-containing samples |
US8852862B2 (en) | 2004-05-03 | 2014-10-07 | Handylab, Inc. | Method for processing polynucleotide-containing samples |
US20090216082A1 (en) * | 2005-04-01 | 2009-08-27 | Elisha Rabinovitz | Device, System and Method for In Vivo Magnetic Immunoassay Analysis |
US7749445B2 (en) * | 2005-05-02 | 2010-07-06 | Bioscale, Inc. | Method and apparatus for analyzing bioprocess fluids |
US7300631B2 (en) * | 2005-05-02 | 2007-11-27 | Bioscale, Inc. | Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles |
CN101238361B (en) * | 2005-08-03 | 2011-08-03 | 日本电波工业株式会社 | Concentration sensor and concentration detection device |
JP5295769B2 (en) * | 2005-08-31 | 2013-09-18 | ティツー・バイオシステムズ・インコーポレーテッド | NMR apparatus for detecting analytes |
US8227261B2 (en) * | 2005-11-23 | 2012-07-24 | Bioscale, Inc. | Methods and apparatus for assay measurements |
JP2009517652A (en) * | 2005-11-25 | 2009-04-30 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Sensitive magnetic capture analysis by construction of strong binding pairs |
EP1963856B1 (en) * | 2005-12-19 | 2014-04-16 | Bioscale, Inc. | Method and apparatus for analyzing bioprocess fluids |
EP2284539B1 (en) * | 2005-12-19 | 2014-04-09 | Bioscale, Inc. | Method and apparatus for analyzing bioprocess fluids |
US11806718B2 (en) | 2006-03-24 | 2023-11-07 | Handylab, Inc. | Fluorescence detector for microfluidic diagnostic system |
US8883490B2 (en) | 2006-03-24 | 2014-11-11 | Handylab, Inc. | Fluorescence detector for microfluidic diagnostic system |
US10900066B2 (en) | 2006-03-24 | 2021-01-26 | Handylab, Inc. | Microfluidic system for amplifying and detecting polynucleotides in parallel |
US7998708B2 (en) | 2006-03-24 | 2011-08-16 | Handylab, Inc. | Microfluidic system for amplifying and detecting polynucleotides in parallel |
US8088616B2 (en) | 2006-03-24 | 2012-01-03 | Handylab, Inc. | Heater unit for microfluidic diagnostic system |
DK2001990T3 (en) | 2006-03-24 | 2016-10-03 | Handylab Inc | Integrated microfluidic sample processing system and method for its use |
WO2007127107A2 (en) * | 2006-04-21 | 2007-11-08 | Bioscale, Inc. | Microfabricated devices and method for fabricating microfabricated devices |
RU2444736C2 (en) * | 2006-05-09 | 2012-03-10 | Конинклейке Филипс Электроникс Н.В. | Target molecule detection in sample |
WO2008061165A2 (en) | 2006-11-14 | 2008-05-22 | Handylab, Inc. | Microfluidic cartridge and method of making same |
US20080118402A1 (en) * | 2006-11-21 | 2008-05-22 | David Brancazio | Method and apparatus for analyte processing |
EP2095103A2 (en) * | 2006-11-21 | 2009-09-02 | Bioscale, Inc. | Method and apparatus for analyte processing |
US20080121042A1 (en) * | 2006-11-27 | 2008-05-29 | Bioscale, Inc. | Fluid paths in etchable materials |
US7999440B2 (en) * | 2006-11-27 | 2011-08-16 | Bioscale, Inc. | Micro-fabricated devices having a suspended membrane or plate structure |
DE102006058374A1 (en) * | 2006-12-08 | 2008-07-03 | Biosensor Gmbh | Analytical method and portable analyzer |
US20100015728A1 (en) * | 2006-12-19 | 2010-01-21 | Iverness Medical Switzerland Gmbh | Assay Device and Method |
US7993525B2 (en) * | 2006-12-29 | 2011-08-09 | Intel Corporation | Device and method for particle complex handling |
US20080245740A1 (en) * | 2007-01-29 | 2008-10-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Fluidic methods |
WO2009005542A2 (en) * | 2007-02-09 | 2009-01-08 | Stc.Unm | Detection of bioagents using a shear horizontal surface acoustic wave biosensor |
EP2137534A1 (en) * | 2007-03-26 | 2009-12-30 | The University of Chicago | Immunoassays and characterization of biomolecular interactions using self- assembled monolayers |
WO2009012185A1 (en) | 2007-07-13 | 2009-01-22 | Handylab, Inc. | Polynucleotide capture materials, and methods of using same |
US9186677B2 (en) | 2007-07-13 | 2015-11-17 | Handylab, Inc. | Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples |
US8182763B2 (en) | 2007-07-13 | 2012-05-22 | Handylab, Inc. | Rack for sample tubes and reagent holders |
US8287820B2 (en) | 2007-07-13 | 2012-10-16 | Handylab, Inc. | Automated pipetting apparatus having a combined liquid pump and pipette head system |
US9618139B2 (en) | 2007-07-13 | 2017-04-11 | Handylab, Inc. | Integrated heater and magnetic separator |
US8105783B2 (en) | 2007-07-13 | 2012-01-31 | Handylab, Inc. | Microfluidic cartridge |
USD621060S1 (en) | 2008-07-14 | 2010-08-03 | Handylab, Inc. | Microfluidic cartridge |
US20090136385A1 (en) * | 2007-07-13 | 2009-05-28 | Handylab, Inc. | Reagent Tube |
US8133671B2 (en) | 2007-07-13 | 2012-03-13 | Handylab, Inc. | Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples |
US20090020463A1 (en) * | 2007-07-18 | 2009-01-22 | Horn-Jiunn Sheen | Triple-channel particle separation device |
WO2009033056A1 (en) * | 2007-09-06 | 2009-03-12 | Bioscale, Inc. | Reusable detection surfaces and methods of using same |
DE102007043281A1 (en) * | 2007-09-11 | 2009-05-28 | Sebastian Dr. med. Chakrit Bhakdi | Apparatus, materials and methods for high gradient magnetic separation of biological material |
US8397762B2 (en) * | 2008-02-04 | 2013-03-19 | Bioscale, Inc. | Fluidic system with improved flow characteristics |
JP5081012B2 (en) * | 2008-02-21 | 2012-11-21 | 株式会社日立エンジニアリング・アンド・サービス | Microbiological testing device |
US8096786B2 (en) * | 2008-02-27 | 2012-01-17 | University Of Massachusetts | Three dimensional micro-fluidic pumps and valves |
US8961902B2 (en) * | 2008-04-23 | 2015-02-24 | Bioscale, Inc. | Method and apparatus for analyte processing |
KR101746861B1 (en) * | 2008-04-24 | 2017-06-14 | 가부시키가이샤 진 테크노 사이언스 | Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
WO2010005444A1 (en) * | 2008-07-11 | 2010-01-14 | Handylab, Inc. | Polynucleotide capture materials, and methods of using same |
USD618820S1 (en) | 2008-07-11 | 2010-06-29 | Handylab, Inc. | Reagent holder |
US20100009351A1 (en) * | 2008-07-11 | 2010-01-14 | Handylab, Inc. | Polynucleotide Capture Materials, and Method of Using Same |
USD787087S1 (en) | 2008-07-14 | 2017-05-16 | Handylab, Inc. | Housing |
KR101468593B1 (en) | 2008-08-14 | 2014-12-04 | 삼성전자주식회사 | Wave sensor apparatus comprising gas removing unit and method of detecting target material in liquid sample |
JP2010071693A (en) * | 2008-09-16 | 2010-04-02 | Fujifilm Corp | Sensing method, sensing device, inspection chip, and inspection kit |
US9123614B2 (en) | 2008-10-07 | 2015-09-01 | Mc10, Inc. | Methods and applications of non-planar imaging arrays |
US8389862B2 (en) | 2008-10-07 | 2013-03-05 | Mc10, Inc. | Extremely stretchable electronics |
WO2010042653A1 (en) | 2008-10-07 | 2010-04-15 | Mc10, Inc. | Catheter balloon having stretchable integrated circuitry and sensor array |
US8097926B2 (en) | 2008-10-07 | 2012-01-17 | Mc10, Inc. | Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy |
EP2350673B1 (en) * | 2008-10-24 | 2022-05-11 | Leica Biosystems Richmond, Inc. | Modular system for performing laboratory protocols and associated methods |
US20100112719A1 (en) * | 2008-11-06 | 2010-05-06 | Amihood Doron | Electronic signal amplification in field effect device based chemical sensors |
US9562855B1 (en) | 2009-12-03 | 2017-02-07 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Devices and methods for detection of microorganisms via MIE scattering |
US9678005B1 (en) | 2008-12-03 | 2017-06-13 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Devices and methods for detection of microorganisms |
US20100136610A1 (en) * | 2008-12-03 | 2010-06-03 | Jeong-Yeol Yoon | Methods And Microfluidic Devices For Single Cell Detection Of Escherichia Coli |
RU2530716C2 (en) * | 2008-12-22 | 2014-10-10 | Конинклейке Филипс Электроникс Н.В. | Analysis of troponin i with application of magnetic labels |
KR101183159B1 (en) * | 2008-12-22 | 2012-09-17 | 한국전자통신연구원 | Biochip and apparatus for detecting bio materials by using the biochip |
EP2219033B1 (en) * | 2008-12-30 | 2016-05-25 | MicroCoat Biotechnologie GmbH | Device, instrument and process for detecting magnetically labeled analytes |
DE102009012108B4 (en) * | 2009-03-06 | 2015-07-16 | Siemens Aktiengesellschaft | Apparatus and method for enrichment and detection of cells in flowing media |
JP2012523576A (en) * | 2009-04-13 | 2012-10-04 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | Method and apparatus for detecting the presence of an analyte in a sample |
US8193808B2 (en) * | 2009-09-11 | 2012-06-05 | Hewlett-Packard Development Company, L.P. | Optically integrated biosensor based on optically detected magnetic resonance |
US8900850B2 (en) * | 2009-09-17 | 2014-12-02 | Michael J. Lane | Lateral flow based methods and assays for rapid and inexpensive diagnostic tests |
EP2480653A4 (en) * | 2009-09-23 | 2013-03-20 | Univ Pennsylvania | Devices and methods for detecting and monitoring hiv and other infections and diseases |
US9723122B2 (en) | 2009-10-01 | 2017-08-01 | Mc10, Inc. | Protective cases with integrated electronics |
WO2011043789A2 (en) * | 2009-10-09 | 2011-04-14 | Micropoint Bioscience Inc. | Inductive coagulation sensors and devices |
GB201002627D0 (en) | 2010-02-16 | 2010-03-31 | Loxbridge Res Llp | Aptamer based analyte detection method |
JP5937019B2 (en) * | 2010-03-12 | 2016-06-22 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | Quantitative analysis of binding kinetics based on magnetic sensor |
WO2011162847A2 (en) | 2010-03-31 | 2011-12-29 | Cornell University | Stress-based sensor, method and applications |
US9476812B2 (en) | 2010-04-21 | 2016-10-25 | Dna Electronics, Inc. | Methods for isolating a target analyte from a heterogeneous sample |
US20140100136A1 (en) * | 2010-04-21 | 2014-04-10 | Nanomr, Inc. | Isolation and characterization of pathogens |
US8841104B2 (en) | 2010-04-21 | 2014-09-23 | Nanomr, Inc. | Methods for isolating a target analyte from a heterogeneous sample |
US20110262989A1 (en) | 2010-04-21 | 2011-10-27 | Nanomr, Inc. | Isolating a target analyte from a body fluid |
US8726989B2 (en) | 2010-07-14 | 2014-05-20 | Donald Nevin | Method for removing contaminants from wastewater in hydraulic fracturing process |
EP3974831A1 (en) | 2010-10-22 | 2022-03-30 | T2 Biosystems, Inc. | Methods for detecting the presence of a bacterium in a whole blood sample |
US8409807B2 (en) | 2010-10-22 | 2013-04-02 | T2 Biosystems, Inc. | NMR systems and methods for the rapid detection of analytes |
US8563298B2 (en) | 2010-10-22 | 2013-10-22 | T2 Biosystems, Inc. | NMR systems and methods for the rapid detection of analytes |
GB201021499D0 (en) | 2010-12-20 | 2011-02-02 | Loxbridge Res Llp | Detection of quantative genetic differnces |
CA2833262C (en) | 2011-04-15 | 2020-08-18 | Becton, Dickinson And Company | Scanning real-time microfluidic thermocycler and methods for synchronized thermocycling and scanning optical detection |
EP2712491B1 (en) | 2011-05-27 | 2019-12-04 | Mc10, Inc. | Flexible electronic structure |
KR20130015634A (en) * | 2011-08-04 | 2013-02-14 | 삼성전자주식회사 | Bioseneor using agglomeration of magnetic nanoparticle and detecting method by the same |
JP6320920B2 (en) | 2011-08-05 | 2018-05-09 | エムシーテン、インコーポレイテッド | Balloon catheter device and sensing method using sensing element |
USD692162S1 (en) | 2011-09-30 | 2013-10-22 | Becton, Dickinson And Company | Single piece reagent holder |
EP2761305B1 (en) | 2011-09-30 | 2017-08-16 | Becton, Dickinson and Company | Unitized reagent strip |
CN104040238B (en) | 2011-11-04 | 2017-06-27 | 汉迪拉布公司 | Polynucleotides sample preparation apparatus |
EP2594940A1 (en) * | 2011-11-16 | 2013-05-22 | Koninklijke Philips Electronics N.V. | Particle repulsion to enhance surface contact in magnetic particle immunoassays |
AU2013214849B2 (en) | 2012-02-03 | 2016-09-01 | Becton, Dickinson And Company | External files for distribution of molecular diagnostic tests and determination of compatibility between tests |
US9562271B2 (en) | 2012-04-20 | 2017-02-07 | T2 Biosystems, Inc. | Compositions and methods for detection of Candida species |
US9226402B2 (en) | 2012-06-11 | 2015-12-29 | Mc10, Inc. | Strain isolation structures for stretchable electronics |
US9168094B2 (en) | 2012-07-05 | 2015-10-27 | Mc10, Inc. | Catheter device including flow sensing |
US9295842B2 (en) | 2012-07-05 | 2016-03-29 | Mc10, Inc. | Catheter or guidewire device including flow sensing and use thereof |
US20140052020A1 (en) * | 2012-08-15 | 2014-02-20 | University Of Florida Research Foundation, Inc. | Magnetic apparatus and methods of use |
RU2653145C2 (en) * | 2012-09-04 | 2018-05-07 | Конинклейке Филипс Н.В. | Sensor device and method of sampling |
US9171794B2 (en) | 2012-10-09 | 2015-10-27 | Mc10, Inc. | Embedding thin chips in polymer |
US9082025B2 (en) | 2012-10-09 | 2015-07-14 | Mc10, Inc. | Conformal electronics integrated with apparel |
US10000557B2 (en) | 2012-12-19 | 2018-06-19 | Dnae Group Holdings Limited | Methods for raising antibodies |
US9995742B2 (en) | 2012-12-19 | 2018-06-12 | Dnae Group Holdings Limited | Sample entry |
US9434940B2 (en) | 2012-12-19 | 2016-09-06 | Dna Electronics, Inc. | Methods for universal target capture |
US9551704B2 (en) | 2012-12-19 | 2017-01-24 | Dna Electronics, Inc. | Target detection |
US9804069B2 (en) | 2012-12-19 | 2017-10-31 | Dnae Group Holdings Limited | Methods for degrading nucleic acid |
US9599610B2 (en) | 2012-12-19 | 2017-03-21 | Dnae Group Holdings Limited | Target capture system |
US9706647B2 (en) | 2013-05-14 | 2017-07-11 | Mc10, Inc. | Conformal electronics including nested serpentine interconnects |
EP3027729A4 (en) * | 2013-07-29 | 2017-04-05 | MBIO Diagnostics Inc. | Assay cartridge processing systems and methods and associated assay cartridges |
WO2015021039A1 (en) | 2013-08-05 | 2015-02-12 | Xia Li | Flexible temperature sensor including conformable electronics |
KR20160065948A (en) | 2013-10-07 | 2016-06-09 | 엠씨10, 인크 | Conformal sensor systems for sensing and analysis |
KR102365120B1 (en) | 2013-11-22 | 2022-02-18 | 메디데이타 솔루션즈, 인코포레이티드 | Conformal sensor systems for sensing and analysis of cardiac activity |
JP6549150B2 (en) | 2014-01-06 | 2019-07-24 | エムシー10 インコーポレイテッドMc10,Inc. | Method of enclosing conformal electronic device |
EP3114911B1 (en) | 2014-03-04 | 2023-05-03 | Medidata Solutions, Inc. | Multi-part flexible encapsulation housing for electronic devices |
US9810623B2 (en) * | 2014-03-12 | 2017-11-07 | Mc10, Inc. | Quantification of a change in assay |
US9899330B2 (en) | 2014-10-03 | 2018-02-20 | Mc10, Inc. | Flexible electronic circuits with embedded integrated circuit die |
US10297572B2 (en) | 2014-10-06 | 2019-05-21 | Mc10, Inc. | Discrete flexible interconnects for modules of integrated circuits |
USD781270S1 (en) | 2014-10-15 | 2017-03-14 | Mc10, Inc. | Electronic device having antenna |
US10101265B1 (en) | 2014-11-07 | 2018-10-16 | Board Of Regents For The University Of Nebraska | Birefringence imaging chromatography based on highly ordered 3D nanostructures |
KR101860543B1 (en) * | 2015-01-09 | 2018-05-24 | 한양대학교 에리카산학협력단 | Reagent kit for detecting sex hormone and method of detecting sex hormone using the same |
WO2016134306A1 (en) | 2015-02-20 | 2016-08-25 | Mc10, Inc. | Automated detection and configuration of wearable devices based on on-body status, location, and/or orientation |
WO2016140961A1 (en) | 2015-03-02 | 2016-09-09 | Mc10, Inc. | Perspiration sensor |
WO2017011393A1 (en) | 2015-07-10 | 2017-01-19 | Stc.Unm | Magnetic resonance spectrometer |
US10653332B2 (en) | 2015-07-17 | 2020-05-19 | Mc10, Inc. | Conductive stiffener, method of making a conductive stiffener, and conductive adhesive and encapsulation layers |
US10709384B2 (en) | 2015-08-19 | 2020-07-14 | Mc10, Inc. | Wearable heat flux devices and methods of use |
WO2017059215A1 (en) | 2015-10-01 | 2017-04-06 | Mc10, Inc. | Method and system for interacting with a virtual environment |
US10532211B2 (en) | 2015-10-05 | 2020-01-14 | Mc10, Inc. | Method and system for neuromodulation and stimulation |
JP2019512208A (en) | 2016-01-21 | 2019-05-16 | ティー2 バイオシステムズ,インコーポレーテッド | NMR method and system for detecting bacteria quickly |
EP3420733A4 (en) | 2016-02-22 | 2019-06-26 | Mc10, Inc. | System, device, and method for coupled hub and sensor node on-body acquisition of sensor information |
CN115175014A (en) | 2016-02-22 | 2022-10-11 | 美谛达解决方案公司 | On-body sensor system |
AU2017229088B2 (en) | 2016-03-07 | 2021-05-13 | X-Zell Inc. | Compositions and methods for identifying rare cells |
CN109310340A (en) | 2016-04-19 | 2019-02-05 | Mc10股份有限公司 | For measuring the method and system of sweat |
US10447347B2 (en) | 2016-08-12 | 2019-10-15 | Mc10, Inc. | Wireless charger and high speed data off-loader |
US11731132B2 (en) * | 2017-12-19 | 2023-08-22 | Biological Dynamics, Inc. | Methods and devices for detection of multiple analytes from a biological sample |
US10362769B1 (en) | 2018-03-23 | 2019-07-30 | International Business Machines Corporation | System and method for detection of disease breakouts |
CN117065932A (en) | 2018-04-02 | 2023-11-17 | 生物动力学公司 | Dielectric material |
US10802090B2 (en) * | 2018-12-21 | 2020-10-13 | Industrial Technology Research Institute | Magnetic biosensor and method of detecting biosignal |
US11280788B2 (en) * | 2019-01-31 | 2022-03-22 | Fresenius Medical Care Holdings, Inc. | Rapid diagnosis of peritonitis in peritoneal dialysis patients |
US20210041429A1 (en) * | 2019-08-07 | 2021-02-11 | AMMR Joint Venture | Transportation and detection of analytes |
CN113008988B (en) * | 2021-02-26 | 2022-05-03 | 中国科学院声学研究所 | Method and device for detecting defects of honeycomb structure |
WO2023074323A1 (en) * | 2021-11-01 | 2023-05-04 | 株式会社日立ハイテク | Immunological measurement method and immunological measurement device |
Citations (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4596697A (en) * | 1984-09-04 | 1986-06-24 | The United States Of America As Represented By The Secretary Of The Army | Chemical sensor matrix |
US4752855A (en) * | 1986-04-16 | 1988-06-21 | Robert Bosch Gmbh | Capacitative-type humidity sensing element and system, and method of manufacture |
US4795698A (en) * | 1985-10-04 | 1989-01-03 | Immunicon Corporation | Magnetic-polymer particles |
US4896098A (en) * | 1987-01-08 | 1990-01-23 | Massachusetts Institute Of Technology | Turbulent shear force microsensor |
US4920450A (en) * | 1989-06-23 | 1990-04-24 | Motorola, Inc. | Temperature dependent capacitor |
US4925788A (en) * | 1986-10-24 | 1990-05-15 | Immunicon Corporation | Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor |
US4997278A (en) * | 1987-08-22 | 1991-03-05 | Amersham International Plc | Biological sensors |
US5023053A (en) * | 1988-05-20 | 1991-06-11 | Amersham International Plc | Biological sensors |
US5025346A (en) * | 1989-02-17 | 1991-06-18 | Regents Of The University Of California | Laterally driven resonant microstructures |
US5079600A (en) * | 1987-03-06 | 1992-01-07 | Schnur Joel M | High resolution patterning on solid substrates |
US5104790A (en) * | 1987-06-29 | 1992-04-14 | Genetic Systems Corporation | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
US5108933A (en) * | 1988-09-16 | 1992-04-28 | Immunicon Corporation | Manipulation of colloids for facilitating magnetic separations |
US5186827A (en) * | 1991-03-25 | 1993-02-16 | Immunicon Corporation | Apparatus for magnetic separation featuring external magnetic means |
US5189914A (en) * | 1988-02-29 | 1993-03-02 | The Regents Of The University Of California | Plate-mode ultrasonic sensor |
US5200084A (en) * | 1990-09-26 | 1993-04-06 | Immunicon Corporation | Apparatus and methods for magnetic separation |
US5199298A (en) * | 1991-06-21 | 1993-04-06 | Massachusetts Institute Of Technology | Wall shear stress sensor |
US5304465A (en) * | 1989-06-12 | 1994-04-19 | Amersham International Plc | Enzyme assay method using surface plasmon resonance spectroscopy |
US5306644A (en) * | 1988-09-29 | 1994-04-26 | Hewlett-Packard Company | Mass sensor method for measuring analytes in a sample |
US5313264A (en) * | 1988-11-10 | 1994-05-17 | Pharmacia Biosensor Ab | Optical biosensor system |
US5411709A (en) * | 1991-03-25 | 1995-05-02 | Fuji Xerox Co., Ltd. | Gas detector |
US5482867A (en) * | 1989-11-13 | 1996-01-09 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
US5490034A (en) * | 1989-01-13 | 1996-02-06 | Kopin Corporation | SOI actuators and microsensors |
US5492840A (en) * | 1988-11-10 | 1996-02-20 | Pharmacia Biosensor Ab | Surface plasmon resonance sensor unit and its use in biosensor systems |
US5512131A (en) * | 1993-10-04 | 1996-04-30 | President And Fellows Of Harvard College | Formation of microstamped patterns on surfaces and derivative articles |
US5593130A (en) * | 1993-06-09 | 1997-01-14 | Pharmacia Biosensor Ab | Valve, especially for fluid handling bodies with microflowchannels |
US5620850A (en) * | 1994-09-26 | 1997-04-15 | President And Fellows Of Harvard College | Molecular recognition at surfaces derivatized with self-assembled monolayers |
US5641640A (en) * | 1992-06-29 | 1997-06-24 | Biacore Ab | Method of assaying for an analyte using surface plasmon resonance |
US5705402A (en) * | 1988-11-03 | 1998-01-06 | Igen International, Inc. | Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets |
US5716854A (en) * | 1990-10-01 | 1998-02-10 | Pharmacia Biosensor Ab | Solid phase binding assay |
US5719324A (en) * | 1995-06-16 | 1998-02-17 | Lockheed Martin Energy Systems, Inc. | Microcantilever sensor |
US5744367A (en) * | 1994-11-10 | 1998-04-28 | Igen International, Inc. | Magnetic particle based electrochemiluminescent detection apparatus and method |
US5753518A (en) * | 1993-05-24 | 1998-05-19 | Pharmacia Ab | Method of determining affinity and kinetic properties |
US5763191A (en) * | 1990-12-12 | 1998-06-09 | Boehringer Mannheim Gmbh | Universal binding film |
US5869748A (en) * | 1994-05-25 | 1999-02-09 | Biosensing Technologies Limited | Acoustic monitor assembly |
US5885527A (en) * | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
US5889351A (en) * | 1994-11-25 | 1999-03-30 | Ngk Insulators, Ltd. | Device for measuring viscosity and device for measuring characteristics of fluid |
US5892144A (en) * | 1995-04-10 | 1999-04-06 | Behringwerke Aktiengesellschaft | Biosensor |
US5900160A (en) * | 1993-10-04 | 1999-05-04 | President And Fellows Of Harvard College | Methods of etching articles via microcontact printing |
US6033852A (en) * | 1996-09-27 | 2000-03-07 | University Of Maine | Monolithic piezoelectric sensor (MPS) for sensing chemical, biochemical and physical measurands |
US6046585A (en) * | 1997-11-21 | 2000-04-04 | Quantum Design, Inc. | Method and apparatus for making quantitative measurements of localized accumulations of target particles having magnetic particles bound thereto |
US6194223B1 (en) * | 1997-04-14 | 2001-02-27 | Roche Diagnostics Gmbh | Method for the simultaneous determination of biomolecular interactions by means of plasmon resonance and fluoresence detection |
US6200814B1 (en) * | 1998-01-20 | 2001-03-13 | Biacore Ab | Method and device for laminar flow on a sensing surface |
US6207381B1 (en) * | 1996-04-04 | 2001-03-27 | Biacore Ab | Method for nucleic acid analysis |
US6208814B1 (en) * | 1997-12-18 | 2001-03-27 | Fuji Photo Film Co., Ltd. | Pre-exposing method for a photographic film and manufacturing method for a lens-fitted film unit |
US6221674B1 (en) * | 1997-04-14 | 2001-04-24 | Roche Diagnostics Gmbh | Process for the application of reagent spots |
US6222619B1 (en) * | 1997-09-18 | 2001-04-24 | University Of Utah Research Foundation | Diagnostic device and method |
US20020012929A1 (en) * | 2000-03-16 | 2002-01-31 | Magnus Malmqvist | Method for capturing analytes eluted from surface-bound ligands |
US6348318B1 (en) * | 1997-04-04 | 2002-02-19 | Biosite Diagnostics | Methods for concentrating ligands using magnetic particles |
US20020028519A1 (en) * | 1996-04-25 | 2002-03-07 | Juan Yguerabide | Analyte assay using particulate labels |
US6365418B1 (en) * | 1998-07-14 | 2002-04-02 | Zyomyx, Incorporated | Arrays of protein-capture agents and methods of use thereof |
US6368877B1 (en) * | 1997-06-25 | 2002-04-09 | Massachusetts Institute Of Technology | Self-assembling peptide surfaces for cell patterning and interactions |
US6368838B1 (en) * | 1993-10-04 | 2002-04-09 | President And Fellows Of Havard College | Adhering cells to cytophilic islands separated by cytophobic regions to form patterns and manipulate cells |
US20020048821A1 (en) * | 2000-08-24 | 2002-04-25 | David Storek | Sample preparing arrangement and a method relating to such an arrangement |
US6391265B1 (en) * | 1996-08-26 | 2002-05-21 | Biosite Diagnostics, Inc. | Devices incorporating filters for filtering fluid samples |
US6506620B1 (en) * | 2000-11-27 | 2003-01-14 | Microscan Systems Incorporated | Process for manufacturing micromechanical and microoptomechanical structures with backside metalization |
US20030010745A1 (en) * | 1996-07-30 | 2003-01-16 | Leslie A. Field | Fabrication of suspended structures using a sacrificial layer |
US20030012693A1 (en) * | 2000-08-24 | 2003-01-16 | Imego Ab | Systems and methods for localizing and analyzing samples on a bio-sensor chip |
US6509059B2 (en) * | 1999-03-08 | 2003-01-21 | Caliper Technologies Corp. | Surface coating for microfluidic devices that incorporate a biopolymer resistant moiety |
US6511915B2 (en) * | 2001-03-26 | 2003-01-28 | Boston Microsystems, Inc. | Electrochemical etching process |
US20030022388A1 (en) * | 2001-06-29 | 2003-01-30 | Biacore Ab | Flow cell method |
US6518747B2 (en) * | 2001-02-16 | 2003-02-11 | Quantum Design, Inc. | Method and apparatus for quantitative determination of accumulations of magnetic particles |
US6518168B1 (en) * | 1995-08-18 | 2003-02-11 | President And Fellows Of Harvard College | Self-assembled monolayer directed patterning of surfaces |
US6544674B2 (en) * | 2000-08-28 | 2003-04-08 | Boston Microsystems, Inc. | Stable electrical contact for silicon carbide devices |
US6551836B1 (en) * | 1998-06-08 | 2003-04-22 | Caliper Technologies Corp. | Microfluidic devices, systems and methods for performing integrated reactions and separations |
US6558944B1 (en) * | 1996-06-28 | 2003-05-06 | Caliper Technologies Corp. | High throughput screening assay systems in microscale fluidic devices |
US20030100762A1 (en) * | 2001-08-27 | 2003-05-29 | Gregory Kaler | Fluorescent dyes |
US20040002167A1 (en) * | 2002-03-27 | 2004-01-01 | Biacore Ab | Method and system for curve quality control |
US20040012431A1 (en) * | 2002-07-17 | 2004-01-22 | Scott Hareland | Semiconductor controlled rectifier / semiconductor controlled switch based esd power supply clamp with active bias timer circuitry |
US20040014179A1 (en) * | 2002-06-20 | 2004-01-22 | Novozymes A/S | Flocculation with divalent salt |
US6681646B1 (en) * | 1998-02-07 | 2004-01-27 | Daimlerchrysler Ag | Multicomponent measuring wheel |
US20040016297A1 (en) * | 2000-08-08 | 2004-01-29 | Frank Paul | Novel device |
US20040023413A1 (en) * | 2001-11-26 | 2004-02-05 | Molecular Reflections, Inc. | Microscale immobilization of molecules using a hydrogel and methods of use thereof |
US6688158B2 (en) * | 2000-03-20 | 2004-02-10 | The Charles Stark Draper Laboratory, Inc. | Flexural plate wave sensor and array |
US20040038195A1 (en) * | 2000-09-20 | 2004-02-26 | Molecular Reflections | Microresonant sensors and methods of use thereof |
US6698454B2 (en) * | 2000-11-02 | 2004-03-02 | Biacore Ab | Valve integrally associated with microfluidic liquid transport assembly |
US20040043615A1 (en) * | 2002-08-30 | 2004-03-04 | Fujikura Ltd. | Manufacturing method of a semiconductor substrate provided with a through hole electrode |
US20040058456A1 (en) * | 2002-05-31 | 2004-03-25 | Biacore Ab | Method of coupling binding agents to a substrate surface |
US6716620B2 (en) * | 2000-04-17 | 2004-04-06 | Purdue Research Foundation | Biosensor and related method |
US6720710B1 (en) * | 1996-01-05 | 2004-04-13 | Berkeley Microinstruments, Inc. | Micropump |
US20040101990A1 (en) * | 2002-11-26 | 2004-05-27 | Dunn Gregory J. | Flexural plate wave systems |
US20050019933A1 (en) * | 2003-06-06 | 2005-01-27 | Biacore Ab | Method and apparatus for characterization of interactions |
US6848299B2 (en) * | 1998-10-26 | 2005-02-01 | Akubio Limited | Quartz crystal microbalance with feedback loop for automatic gain control |
US6848295B2 (en) * | 2002-04-17 | 2005-02-01 | Wayne State University | Acoustic wave sensor apparatus, method and system using wide bandgap materials |
US20050057302A1 (en) * | 2003-05-02 | 2005-03-17 | Andle Jeffrey C. | Temperature compensated, high efficiency, controlled input impedance diode detector |
US20050064619A1 (en) * | 2002-02-04 | 2005-03-24 | Delphi Technologies, Inc. | Process for a monolithically-integrated micromachined sensor and circuit |
US20050074904A1 (en) * | 2003-09-10 | 2005-04-07 | Auburn University | Magnetostrictive ligand sensor |
US20050082944A1 (en) * | 2001-08-28 | 2005-04-21 | Michael Thompson | Electromagnetic piezoelectric acoustic sensor |
US6901278B1 (en) * | 2002-01-29 | 2005-05-31 | Morris Notelovitz | Methods for reducing the risk of breast cancer in and improving the health of women |
US20060019330A1 (en) * | 2003-12-30 | 2006-01-26 | 3M Innovative Properties Company | Staphylococcus detection |
US20070037231A1 (en) * | 2005-05-02 | 2007-02-15 | Bioscale, Inc. | Methods and apparatus for detecting bacteria using an acoustic device |
US20070034142A1 (en) * | 2005-08-09 | 2007-02-15 | Laura Pescini | Methods of forming nanocrystals |
Family Cites Families (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4098876A (en) * | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
US4551435A (en) | 1983-08-24 | 1985-11-05 | Immunicon, Inc. | Selective removal of immunospecifically recognizable substances from solution |
US4847193A (en) | 1987-06-18 | 1989-07-11 | Gene-Trak Systems | Signal amplification in an assay employing a piezoelectric oscillator |
GB8801807D0 (en) | 1988-01-27 | 1988-02-24 | Amersham Int Plc | Biological sensors |
WO1989008336A1 (en) * | 1988-02-29 | 1989-09-08 | The Regents Of The University Of California | Plate-mode ultrasonic sensor |
EP0341928A1 (en) * | 1988-05-10 | 1989-11-15 | AMERSHAM INTERNATIONAL plc | Improvements relating to surface plasmon resonance sensors |
DE68907519T2 (en) | 1988-05-10 | 1993-10-21 | Amersham Int Plc | Biosensors. |
GB8813307D0 (en) | 1988-06-06 | 1988-07-13 | Amersham Int Plc | Biological sensors |
SE8902043L (en) | 1988-11-10 | 1990-05-11 | Pharmacia Ab | PROCEDURE CHARACTERIZES MACROMOLECULES |
SE462454B (en) * | 1988-11-10 | 1990-06-25 | Pharmacia Ab | METHOD FOR USE IN BIOSENSORS |
US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
EP0455067B1 (en) | 1990-05-03 | 2003-02-26 | F. Hoffmann-La Roche Ag | Micro-optical sensor |
SE470347B (en) | 1990-05-10 | 1994-01-31 | Pharmacia Lkb Biotech | Microstructure for fluid flow systems and process for manufacturing such a system |
US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
IL100867A (en) * | 1991-02-06 | 1995-12-08 | Igen Inc | Method and apparatus for improved luminescence assays |
SE9100392D0 (en) | 1991-02-08 | 1991-02-08 | Pharmacia Biosensor Ab | A METHOD OF PRODUCING A SEALING MEANS IN A MICROFLUIDIC STRUCTURE AND A MICROFLUIDIC STRUCTURE COMPRISING SUCH SEALING MEANS |
JPH04320967A (en) * | 1991-02-27 | 1992-11-11 | Nec Corp | Immunity sensor |
US5074149A (en) | 1991-03-26 | 1991-12-24 | Xerox Corporation | Acoustic wave measurement of the properties of porous materials filled with air and granules |
US5235235A (en) | 1991-05-24 | 1993-08-10 | The United States Of America As Represented By The United States Department Of Energy | Multiple-frequency acoustic wave devices for chemical sensing and materials characterization in both gas and liquid phase |
US5339051A (en) | 1991-12-09 | 1994-08-16 | Sandia Corporation | Micro-machined resonator oscillator |
JP2962031B2 (en) * | 1992-02-24 | 1999-10-12 | 日本電気株式会社 | Immunoassay method |
US5445971A (en) * | 1992-03-20 | 1995-08-29 | Abbott Laboratories | Magnetically assisted binding assays using magnetically labeled binding members |
DE59305466D1 (en) | 1992-04-30 | 1997-03-27 | Fraunhofer Ges Forschung | SENSOR WITH HIGH SENSITIVITY |
US5458852A (en) | 1992-05-21 | 1995-10-17 | Biosite Diagnostics, Inc. | Diagnostic devices for the controlled movement of reagents without membranes |
US6156270A (en) | 1992-05-21 | 2000-12-05 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
US6905882B2 (en) * | 1992-05-21 | 2005-06-14 | Biosite, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
GB9212416D0 (en) | 1992-06-11 | 1992-07-22 | Medical Res Council | Reversible binding substances |
JPH0650974A (en) * | 1992-07-29 | 1994-02-25 | Nec Corp | Immunological sensor system and immunoassay using the same |
US5656504A (en) | 1992-10-26 | 1997-08-12 | Pharmacia Biosensor Ab | Method of preventing undesired binding in solid phase assays |
US5374792A (en) | 1993-01-04 | 1994-12-20 | General Electric Company | Micromechanical moving structures including multiple contact switching system |
DE59410197D1 (en) | 1993-03-26 | 2002-11-21 | Hoffmann La Roche | Optical method and device for analyzing substances on sensor surfaces |
DE4310025A1 (en) | 1993-03-27 | 1994-09-29 | Boehringer Mannheim Gmbh | Device for the laterally resolved examination of a laterally heterogeneous ultra-thin object layer |
SE501108C2 (en) | 1993-04-08 | 1994-11-14 | Pharmacia Lkb Biotech | Method and apparatus for determining refractive index |
DE4342942A1 (en) * | 1993-12-16 | 1995-06-22 | Boehringer Mannheim Gmbh | Device and method for generating optically detectable signals by applying electrical potentials to sample liquids |
DE4435728A1 (en) | 1994-01-19 | 1995-07-20 | Boehringer Mannheim Gmbh | Biotin silane compounds and binding matrix containing these compounds |
US5445178A (en) | 1994-02-18 | 1995-08-29 | Feuer; Lenny | Soil moisture sensor |
US6306614B1 (en) | 1994-06-08 | 2001-10-23 | Sepsis, Inc. | Measurement of analytes in whole blood |
US5995729A (en) | 1994-07-22 | 1999-11-30 | Hitachi, Ltd. | Method and apparatus for aiding configurating management of a computer system |
US5656428A (en) | 1994-09-08 | 1997-08-12 | Biode, Inc. | Homogeneous bioassay using acoustic emission spectroscopy |
SE9403245D0 (en) * | 1994-09-26 | 1994-09-26 | Pharmacia Biosensor Ab | Improvements relating to bilayer lipid membranes |
WO1996010076A1 (en) * | 1994-09-28 | 1996-04-04 | Spectral Diagnostics Inc. | A monoclonal antibody to human cardiac troponin i |
AU4213396A (en) * | 1995-01-26 | 1996-08-01 | Nippon Paint Co., Ltd. | Kit for immunologically assaying biological substance and assay process |
US5795725A (en) | 1995-04-18 | 1998-08-18 | Biosite Diagnostics Incorporated | Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays |
SE504199C2 (en) | 1995-05-04 | 1996-12-02 | Bengt Kasemo | Device for measuring resonant frequency and / or dissipation factor of a piezoelectric crystal microwave |
SE9502608D0 (en) | 1995-07-14 | 1995-07-14 | Pharmacia Biosensor Ab | Method for nucleic acid sequencing |
SE9503028D0 (en) | 1995-09-01 | 1995-09-01 | Pharmacia Biosensor Ab | Method of analyzing chemical and physical interactions on a sensor surface |
GB9518429D0 (en) | 1995-09-08 | 1995-11-08 | Pharmacia Biosensor | A rapid method for providing kinetic and structural data in molecular interaction analysis |
JP3300583B2 (en) * | 1995-11-10 | 2002-07-08 | 幹男 中山 | Antigen or antibody detection sheet, detection kit and detection method |
SE9504046D0 (en) | 1995-11-14 | 1995-11-14 | Pharmacia Ab | Method of determining affinity and kinetic properties |
US5855940A (en) * | 1996-04-12 | 1999-01-05 | University Of Arkansas | Method for the broad spectrum prevention and removal of microbial contamination of poultry and meat products by quaternary ammonium compounds |
US5885470A (en) | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
DE19618926A1 (en) | 1996-05-10 | 1997-11-13 | Boehringer Mannheim Gmbh | Surface coated with amino groups |
US5836203A (en) * | 1996-10-21 | 1998-11-17 | Sandia Corporation | Magnetically excited flexural plate wave apparatus |
US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
US5998224A (en) | 1997-05-16 | 1999-12-07 | Abbott Laboratories | Magnetically assisted binding assays utilizing a magnetically responsive reagent |
US5932953A (en) | 1997-06-30 | 1999-08-03 | Iowa State University Research Foundation, Inc. | Method and system for detecting material using piezoelectric resonators |
US6106779A (en) | 1997-10-02 | 2000-08-22 | Biosite Diagnostics, Inc. | Lysis chamber for use in an assay device |
US5842787A (en) | 1997-10-09 | 1998-12-01 | Caliper Technologies Corporation | Microfluidic systems incorporating varied channel dimensions |
US6123819A (en) | 1997-11-12 | 2000-09-26 | Protiveris, Inc. | Nanoelectrode arrays |
US5912181A (en) * | 1997-12-23 | 1999-06-15 | Petcavich; Robert J. | Method for molecule detection utilizing digital micromirror technology |
US6289286B1 (en) | 1998-05-29 | 2001-09-11 | Biacore Ab | Surface regeneration of biosensors and characterization of biomolecules associated therewith |
US6576478B1 (en) * | 1998-07-14 | 2003-06-10 | Zyomyx, Inc. | Microdevices for high-throughput screening of biomolecules |
US6295861B1 (en) | 1999-01-28 | 2001-10-02 | Advanced Technology Materials, Inc. | Quartz crystal microbalance sensors and semiconductor manufacturing process systems comprising same |
US6008893A (en) | 1999-03-22 | 1999-12-28 | Biacore Ab | Reversible-flow conduit system |
US6086821A (en) | 1999-03-29 | 2000-07-11 | The United States Of America As Represented By The Secretary Of The Navy | Ultrasonic force differentiation assay |
US6143513A (en) | 1999-06-23 | 2000-11-07 | Biacore Ab | Method and kit for detecting betalactam-containing compounds |
US6302919B1 (en) | 1999-07-20 | 2001-10-16 | Brian Chambers | Reverse-flow centrifugal filtration method |
US7198702B1 (en) * | 1999-09-30 | 2007-04-03 | Wako Pure Chemical Industries, Ltd. | Method for separating substances using dielectrophoretic forces |
KR20020064915A (en) * | 1999-11-29 | 2002-08-10 | 에이브이아이 바이오파마 인코포레이티드 | Antisense antibacterial method and composition |
US6275137B1 (en) * | 2000-02-08 | 2001-08-14 | Boston Microsystems, Inc. | Semiconductor piezoresistor |
US6953977B2 (en) * | 2000-02-08 | 2005-10-11 | Boston Microsystems, Inc. | Micromechanical piezoelectric device |
US6897015B2 (en) * | 2000-03-07 | 2005-05-24 | Bioforce Nanosciences, Inc. | Device and method of use for detection and characterization of pathogens and biological materials |
US6287758B1 (en) | 2000-03-23 | 2001-09-11 | Axiom Biotechnologies, Inc. | Methods of registering trans-membrane electric potentials |
WO2002016904A2 (en) * | 2000-08-23 | 2002-02-28 | Imego Ab | Microfluidic device and method with transport of magnetic particles into and out of wells |
US20020164819A1 (en) * | 2001-05-02 | 2002-11-07 | David Storek | Sample preparing arrangement and a method relating to such an arrangement |
FR2814454B1 (en) * | 2000-09-27 | 2002-12-20 | Degremont | PROCESS FOR THE PURIFICATION OF WASTEWATER FOR THE ELIMINATION OF NITROGEN AND PHOSPHATE POLLUTIONS |
US6514556B2 (en) * | 2000-12-15 | 2003-02-04 | Ecolab Inc. | Method and composition for washing poultry during processing |
US6587575B1 (en) * | 2001-02-09 | 2003-07-01 | The United States Of America As Represented By The Secretary Of Agriculture | Method and system for contaminant detection during food processing |
EP2261669A1 (en) * | 2001-05-04 | 2010-12-15 | Alere San Diego, Inc. | Diagnostic markers of acute coronary syndromes and methods of use thereof |
CA2453141A1 (en) * | 2001-07-09 | 2003-01-23 | Arizona Board Of Regents A Body Corporate Acting On Behalf Of Arizona State University | Afinity biosensor for monitoring of biological process |
MXPA04004485A (en) * | 2001-11-12 | 2004-09-13 | Upjohn Co | Salmonella vaccine. |
US20030154031A1 (en) * | 2002-02-14 | 2003-08-14 | General Electric Company | Method and apparatus for the rapid evaluation of a plurality of materials or samples |
TWI308214B (en) * | 2002-09-10 | 2009-04-01 | Univ Nat Central | Method of forming a biochip and application thereof |
KR20040047144A (en) * | 2002-11-29 | 2004-06-05 | 신-황 첸 | Microvolume detecting method and device |
US6861251B2 (en) * | 2003-02-24 | 2005-03-01 | Pritest, Inc. | Translucent solid matrix assay device for microarray analysis |
US7373255B2 (en) * | 2003-06-06 | 2008-05-13 | Biacore Ab | Method and system for determination of molecular interaction parameters |
US7118922B1 (en) * | 2003-08-15 | 2006-10-10 | University Of South Florida | System and method for immunosensor regeneration |
WO2005080989A1 (en) * | 2004-02-13 | 2005-09-01 | Molecular Probes, Inc. | Biotin recognition sensors and high-throughput assays |
TWI269038B (en) * | 2005-06-21 | 2006-12-21 | Ind Tech Res Inst | Analytic method and device by utilizing magnetic materials |
-
2005
- 2005-07-18 US US11/183,484 patent/US7300631B2/en active Active
-
2006
- 2006-05-02 KR KR1020077028058A patent/KR101257527B1/en not_active IP Right Cessation
- 2006-05-02 WO PCT/US2006/016809 patent/WO2007030155A2/en active Application Filing
- 2006-05-02 KR KR1020077028045A patent/KR20080016595A/en not_active Application Discontinuation
- 2006-05-02 WO PCT/US2006/016874 patent/WO2006119308A2/en active Application Filing
- 2006-05-02 US US11/417,005 patent/US7598094B2/en not_active Expired - Fee Related
- 2006-05-02 US US11/416,998 patent/US7629137B2/en not_active Expired - Fee Related
- 2006-05-02 US US11/417,000 patent/US7615381B2/en not_active Expired - Fee Related
- 2006-05-02 US US11/416,997 patent/US7632638B2/en not_active Expired - Fee Related
- 2006-05-02 JP JP2008510128A patent/JP2008541052A/en active Pending
- 2006-05-02 JP JP2008510142A patent/JP5197357B2/en not_active Expired - Fee Related
- 2006-05-02 EP EP06824726.1A patent/EP1891441B1/en not_active Not-in-force
- 2006-05-02 EP EP06752113A patent/EP1886142A2/en not_active Withdrawn
-
2007
- 2007-02-21 US US11/709,068 patent/US20070281371A1/en not_active Abandoned
-
2012
- 2012-09-10 JP JP2012198586A patent/JP2013015533A/en active Pending
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4596697A (en) * | 1984-09-04 | 1986-06-24 | The United States Of America As Represented By The Secretary Of The Army | Chemical sensor matrix |
US4795698A (en) * | 1985-10-04 | 1989-01-03 | Immunicon Corporation | Magnetic-polymer particles |
US4752855A (en) * | 1986-04-16 | 1988-06-21 | Robert Bosch Gmbh | Capacitative-type humidity sensing element and system, and method of manufacture |
US4925788A (en) * | 1986-10-24 | 1990-05-15 | Immunicon Corporation | Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor |
US4896098A (en) * | 1987-01-08 | 1990-01-23 | Massachusetts Institute Of Technology | Turbulent shear force microsensor |
US5079600A (en) * | 1987-03-06 | 1992-01-07 | Schnur Joel M | High resolution patterning on solid substrates |
US5104790A (en) * | 1987-06-29 | 1992-04-14 | Genetic Systems Corporation | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
US4997278A (en) * | 1987-08-22 | 1991-03-05 | Amersham International Plc | Biological sensors |
US5189914A (en) * | 1988-02-29 | 1993-03-02 | The Regents Of The University Of California | Plate-mode ultrasonic sensor |
US5023053A (en) * | 1988-05-20 | 1991-06-11 | Amersham International Plc | Biological sensors |
US5108933A (en) * | 1988-09-16 | 1992-04-28 | Immunicon Corporation | Manipulation of colloids for facilitating magnetic separations |
US5306644A (en) * | 1988-09-29 | 1994-04-26 | Hewlett-Packard Company | Mass sensor method for measuring analytes in a sample |
US5705402A (en) * | 1988-11-03 | 1998-01-06 | Igen International, Inc. | Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets |
US5492840A (en) * | 1988-11-10 | 1996-02-20 | Pharmacia Biosensor Ab | Surface plasmon resonance sensor unit and its use in biosensor systems |
US5313264A (en) * | 1988-11-10 | 1994-05-17 | Pharmacia Biosensor Ab | Optical biosensor system |
US5490034A (en) * | 1989-01-13 | 1996-02-06 | Kopin Corporation | SOI actuators and microsensors |
US5025346A (en) * | 1989-02-17 | 1991-06-18 | Regents Of The University Of California | Laterally driven resonant microstructures |
US5304465A (en) * | 1989-06-12 | 1994-04-19 | Amersham International Plc | Enzyme assay method using surface plasmon resonance spectroscopy |
US4920450A (en) * | 1989-06-23 | 1990-04-24 | Motorola, Inc. | Temperature dependent capacitor |
US5482867A (en) * | 1989-11-13 | 1996-01-09 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
US5200084A (en) * | 1990-09-26 | 1993-04-06 | Immunicon Corporation | Apparatus and methods for magnetic separation |
US5716854A (en) * | 1990-10-01 | 1998-02-10 | Pharmacia Biosensor Ab | Solid phase binding assay |
US5763191A (en) * | 1990-12-12 | 1998-06-09 | Boehringer Mannheim Gmbh | Universal binding film |
US5411709A (en) * | 1991-03-25 | 1995-05-02 | Fuji Xerox Co., Ltd. | Gas detector |
US5186827A (en) * | 1991-03-25 | 1993-02-16 | Immunicon Corporation | Apparatus for magnetic separation featuring external magnetic means |
US5199298A (en) * | 1991-06-21 | 1993-04-06 | Massachusetts Institute Of Technology | Wall shear stress sensor |
US6019944A (en) * | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
US5885527A (en) * | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
US5641640A (en) * | 1992-06-29 | 1997-06-24 | Biacore Ab | Method of assaying for an analyte using surface plasmon resonance |
US5753518A (en) * | 1993-05-24 | 1998-05-19 | Pharmacia Ab | Method of determining affinity and kinetic properties |
US5593130A (en) * | 1993-06-09 | 1997-01-14 | Pharmacia Biosensor Ab | Valve, especially for fluid handling bodies with microflowchannels |
US6368838B1 (en) * | 1993-10-04 | 2002-04-09 | President And Fellows Of Havard College | Adhering cells to cytophilic islands separated by cytophobic regions to form patterns and manipulate cells |
US5512131A (en) * | 1993-10-04 | 1996-04-30 | President And Fellows Of Harvard College | Formation of microstamped patterns on surfaces and derivative articles |
US5900160A (en) * | 1993-10-04 | 1999-05-04 | President And Fellows Of Harvard College | Methods of etching articles via microcontact printing |
US5869748A (en) * | 1994-05-25 | 1999-02-09 | Biosensing Technologies Limited | Acoustic monitor assembly |
US6197515B1 (en) * | 1994-09-26 | 2001-03-06 | Harvard University | Molecular recognition at surfaces derivatized with self-assembled monolayers |
US20020042074A1 (en) * | 1994-09-26 | 2002-04-11 | President And Fellows Of Harvard College | Molecular recognition at surfaces derivatized with self-assembled monolayers |
US5620850A (en) * | 1994-09-26 | 1997-04-15 | President And Fellows Of Harvard College | Molecular recognition at surfaces derivatized with self-assembled monolayers |
US5744367A (en) * | 1994-11-10 | 1998-04-28 | Igen International, Inc. | Magnetic particle based electrochemiluminescent detection apparatus and method |
US5889351A (en) * | 1994-11-25 | 1999-03-30 | Ngk Insulators, Ltd. | Device for measuring viscosity and device for measuring characteristics of fluid |
US5892144A (en) * | 1995-04-10 | 1999-04-06 | Behringwerke Aktiengesellschaft | Biosensor |
US5719324A (en) * | 1995-06-16 | 1998-02-17 | Lockheed Martin Energy Systems, Inc. | Microcantilever sensor |
US6518168B1 (en) * | 1995-08-18 | 2003-02-11 | President And Fellows Of Harvard College | Self-assembled monolayer directed patterning of surfaces |
US6720710B1 (en) * | 1996-01-05 | 2004-04-13 | Berkeley Microinstruments, Inc. | Micropump |
US6207381B1 (en) * | 1996-04-04 | 2001-03-27 | Biacore Ab | Method for nucleic acid analysis |
US20020028519A1 (en) * | 1996-04-25 | 2002-03-07 | Juan Yguerabide | Analyte assay using particulate labels |
US6558944B1 (en) * | 1996-06-28 | 2003-05-06 | Caliper Technologies Corp. | High throughput screening assay systems in microscale fluidic devices |
US20030010745A1 (en) * | 1996-07-30 | 2003-01-16 | Leslie A. Field | Fabrication of suspended structures using a sacrificial layer |
US6391265B1 (en) * | 1996-08-26 | 2002-05-21 | Biosite Diagnostics, Inc. | Devices incorporating filters for filtering fluid samples |
US20030035758A1 (en) * | 1996-08-26 | 2003-02-20 | Biosite Incorporated | Devices for incorporating filters for filtering fluid samples |
US6033852A (en) * | 1996-09-27 | 2000-03-07 | University Of Maine | Monolithic piezoelectric sensor (MPS) for sensing chemical, biochemical and physical measurands |
US6348318B1 (en) * | 1997-04-04 | 2002-02-19 | Biosite Diagnostics | Methods for concentrating ligands using magnetic particles |
US6221674B1 (en) * | 1997-04-14 | 2001-04-24 | Roche Diagnostics Gmbh | Process for the application of reagent spots |
US6194223B1 (en) * | 1997-04-14 | 2001-02-27 | Roche Diagnostics Gmbh | Method for the simultaneous determination of biomolecular interactions by means of plasmon resonance and fluoresence detection |
US6368877B1 (en) * | 1997-06-25 | 2002-04-09 | Massachusetts Institute Of Technology | Self-assembling peptide surfaces for cell patterning and interactions |
US6222619B1 (en) * | 1997-09-18 | 2001-04-24 | University Of Utah Research Foundation | Diagnostic device and method |
US6046585A (en) * | 1997-11-21 | 2000-04-04 | Quantum Design, Inc. | Method and apparatus for making quantitative measurements of localized accumulations of target particles having magnetic particles bound thereto |
US6208814B1 (en) * | 1997-12-18 | 2001-03-27 | Fuji Photo Film Co., Ltd. | Pre-exposing method for a photographic film and manufacturing method for a lens-fitted film unit |
US6200814B1 (en) * | 1998-01-20 | 2001-03-13 | Biacore Ab | Method and device for laminar flow on a sensing surface |
US6681646B1 (en) * | 1998-02-07 | 2004-01-27 | Daimlerchrysler Ag | Multicomponent measuring wheel |
US6551836B1 (en) * | 1998-06-08 | 2003-04-22 | Caliper Technologies Corp. | Microfluidic devices, systems and methods for performing integrated reactions and separations |
US6365418B1 (en) * | 1998-07-14 | 2002-04-02 | Zyomyx, Incorporated | Arrays of protein-capture agents and methods of use thereof |
US6848299B2 (en) * | 1998-10-26 | 2005-02-01 | Akubio Limited | Quartz crystal microbalance with feedback loop for automatic gain control |
US6509059B2 (en) * | 1999-03-08 | 2003-01-21 | Caliper Technologies Corp. | Surface coating for microfluidic devices that incorporate a biopolymer resistant moiety |
US6503760B2 (en) * | 2000-03-16 | 2003-01-07 | Biacore Ab | Method for capturing analytes eluted from surface-bound ligands |
US20020012929A1 (en) * | 2000-03-16 | 2002-01-31 | Magnus Malmqvist | Method for capturing analytes eluted from surface-bound ligands |
US6688158B2 (en) * | 2000-03-20 | 2004-02-10 | The Charles Stark Draper Laboratory, Inc. | Flexural plate wave sensor and array |
US6716620B2 (en) * | 2000-04-17 | 2004-04-06 | Purdue Research Foundation | Biosensor and related method |
US20040016297A1 (en) * | 2000-08-08 | 2004-01-29 | Frank Paul | Novel device |
US20020048821A1 (en) * | 2000-08-24 | 2002-04-25 | David Storek | Sample preparing arrangement and a method relating to such an arrangement |
US20030012693A1 (en) * | 2000-08-24 | 2003-01-16 | Imego Ab | Systems and methods for localizing and analyzing samples on a bio-sensor chip |
US6544674B2 (en) * | 2000-08-28 | 2003-04-08 | Boston Microsystems, Inc. | Stable electrical contact for silicon carbide devices |
US20050040907A1 (en) * | 2000-09-20 | 2005-02-24 | Molecular Reflections | System and method for processing capacitive signals |
US20040038195A1 (en) * | 2000-09-20 | 2004-02-26 | Molecular Reflections | Microresonant sensors and methods of use thereof |
US20040043423A1 (en) * | 2000-09-20 | 2004-03-04 | Molecular Reflections | Substrates having through-hole vias and method of making same |
US6698454B2 (en) * | 2000-11-02 | 2004-03-02 | Biacore Ab | Valve integrally associated with microfluidic liquid transport assembly |
US6506620B1 (en) * | 2000-11-27 | 2003-01-14 | Microscan Systems Incorporated | Process for manufacturing micromechanical and microoptomechanical structures with backside metalization |
US6518747B2 (en) * | 2001-02-16 | 2003-02-11 | Quantum Design, Inc. | Method and apparatus for quantitative determination of accumulations of magnetic particles |
US6511915B2 (en) * | 2001-03-26 | 2003-01-28 | Boston Microsystems, Inc. | Electrochemical etching process |
US20030022388A1 (en) * | 2001-06-29 | 2003-01-30 | Biacore Ab | Flow cell method |
US20030100762A1 (en) * | 2001-08-27 | 2003-05-29 | Gregory Kaler | Fluorescent dyes |
US20050082944A1 (en) * | 2001-08-28 | 2005-04-21 | Michael Thompson | Electromagnetic piezoelectric acoustic sensor |
US20040023413A1 (en) * | 2001-11-26 | 2004-02-05 | Molecular Reflections, Inc. | Microscale immobilization of molecules using a hydrogel and methods of use thereof |
US6901278B1 (en) * | 2002-01-29 | 2005-05-31 | Morris Notelovitz | Methods for reducing the risk of breast cancer in and improving the health of women |
US20050064619A1 (en) * | 2002-02-04 | 2005-03-24 | Delphi Technologies, Inc. | Process for a monolithically-integrated micromachined sensor and circuit |
US20040002167A1 (en) * | 2002-03-27 | 2004-01-01 | Biacore Ab | Method and system for curve quality control |
US6848295B2 (en) * | 2002-04-17 | 2005-02-01 | Wayne State University | Acoustic wave sensor apparatus, method and system using wide bandgap materials |
US20040058456A1 (en) * | 2002-05-31 | 2004-03-25 | Biacore Ab | Method of coupling binding agents to a substrate surface |
US20040014179A1 (en) * | 2002-06-20 | 2004-01-22 | Novozymes A/S | Flocculation with divalent salt |
US20040012431A1 (en) * | 2002-07-17 | 2004-01-22 | Scott Hareland | Semiconductor controlled rectifier / semiconductor controlled switch based esd power supply clamp with active bias timer circuitry |
US20040043615A1 (en) * | 2002-08-30 | 2004-03-04 | Fujikura Ltd. | Manufacturing method of a semiconductor substrate provided with a through hole electrode |
US20040101990A1 (en) * | 2002-11-26 | 2004-05-27 | Dunn Gregory J. | Flexural plate wave systems |
US20050057302A1 (en) * | 2003-05-02 | 2005-03-17 | Andle Jeffrey C. | Temperature compensated, high efficiency, controlled input impedance diode detector |
US20050019933A1 (en) * | 2003-06-06 | 2005-01-27 | Biacore Ab | Method and apparatus for characterization of interactions |
US20050074904A1 (en) * | 2003-09-10 | 2005-04-07 | Auburn University | Magnetostrictive ligand sensor |
US20060019330A1 (en) * | 2003-12-30 | 2006-01-26 | 3M Innovative Properties Company | Staphylococcus detection |
US20070037231A1 (en) * | 2005-05-02 | 2007-02-15 | Bioscale, Inc. | Methods and apparatus for detecting bacteria using an acoustic device |
US20070042441A1 (en) * | 2005-05-02 | 2007-02-22 | Bioscale, Inc. | Method and apparatus for detecting estradiol and metabolites thereof using an acoustic device |
US20070034142A1 (en) * | 2005-08-09 | 2007-02-15 | Laura Pescini | Methods of forming nanocrystals |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8435463B2 (en) | 2006-11-21 | 2013-05-07 | Bioscale, Inc. | Method and apparatus for analyte processing |
WO2010087985A2 (en) | 2009-01-28 | 2010-08-05 | Yale University | Novel markers for detection of complications resulting from in utero encounters |
WO2013158045A1 (en) * | 2012-04-20 | 2013-10-24 | Agency For Science, Technology And Research | Microfilter and apparatus for separating a biological entity from a sample volume |
US20140340681A1 (en) * | 2013-05-17 | 2014-11-20 | Azbil Corporation | Particle detecting device and particle detecting method |
US9297740B2 (en) * | 2013-05-17 | 2016-03-29 | Azbil Corporation | Particle detecting device and particle detecting method |
Also Published As
Publication number | Publication date |
---|---|
WO2006119308A3 (en) | 2007-04-12 |
US20070042441A1 (en) | 2007-02-22 |
US20070037231A1 (en) | 2007-02-15 |
KR20080016595A (en) | 2008-02-21 |
WO2007030155A2 (en) | 2007-03-15 |
EP1886142A2 (en) | 2008-02-13 |
US7615381B2 (en) | 2009-11-10 |
US7629137B2 (en) | 2009-12-08 |
EP1891441B1 (en) | 2018-12-19 |
JP2013015533A (en) | 2013-01-24 |
EP1891441A2 (en) | 2008-02-27 |
JP2008541053A (en) | 2008-11-20 |
US7300631B2 (en) | 2007-11-27 |
US7598094B2 (en) | 2009-10-06 |
WO2006119308A2 (en) | 2006-11-09 |
US20060257945A1 (en) | 2006-11-16 |
KR20080027239A (en) | 2008-03-26 |
US7632638B2 (en) | 2009-12-15 |
WO2007030155A3 (en) | 2007-05-10 |
JP2008541052A (en) | 2008-11-20 |
KR101257527B1 (en) | 2013-04-23 |
JP5197357B2 (en) | 2013-05-15 |
US20070037142A1 (en) | 2007-02-15 |
US20060286685A1 (en) | 2006-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7300631B2 (en) | Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles | |
US8227261B2 (en) | Methods and apparatus for assay measurements | |
US7749445B2 (en) | Method and apparatus for analyzing bioprocess fluids | |
EP2579988B1 (en) | Non-linear magnetophoretic separation system and method | |
EP1963856B1 (en) | Method and apparatus for analyzing bioprocess fluids | |
US7648844B2 (en) | Method and apparatus for detection of analyte using an acoustic device | |
US10151750B2 (en) | Magnetic and/or electric label assisted detection system and method | |
US7611908B2 (en) | Method and apparatus for therapeutic drug monitoring using an acoustic device | |
JP2005522679A (en) | Immunoassay probe | |
EP2284539B1 (en) | Method and apparatus for analyzing bioprocess fluids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BIOSCALE, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MILLER, MICHAEL F.;MASTERS, BRETT P.;LUNDSTROM, MARK E.;REEL/FRAME:019623/0218;SIGNING DATES FROM 20070619 TO 20070720 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: PROTERIXBIO, INC., MASSACHUSETTS Free format text: CHANGE OF NAME;ASSIGNOR:BIOSCALE, INC.;REEL/FRAME:039069/0923 Effective date: 20160427 |